Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~October 26, 2021,~~April 22, 2022, the registrant had ~~86,006,357~~94,180,160 shares of common stock, $0.001 par value per share, outstanding.

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “should,” “expects,” “plans,” “anticipates,” “would,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of risks, uncertainties and assumptions described in the “Risk Factors” section and elsewhere in this Quarterly Report on Form 10-Q. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Some of the key factors that could cause actual results to differ from our expectations include:

Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events or otherwise.

	September 30,			December 31,			March 31,			December 31,
	2021			2020			2022			2021
Assets
Current assets:
Cash and cash equivalents	$	156,460		$	157,455		$	168,580		$	154,703
Accounts receivable, net of provision for doubtful accounts of $121 and $58 as of September 30, 2021 and December 31, 2020, respectively		80,863			94,124
Accounts receivable, net of provision for doubtful accounts of $370 and $117 as of March 31, 2022 and December 31, 2021, respectively								48,106			85,774
Inventory		91,853			101,204			85,284			84,828
Prepaid expenses and other current assets		4,485			3,864			6,052			5,746
Prepaid income taxes		19,956			14,087			2,627			23,963
Total current assets		353,617			370,734			310,649			355,014
Property and equipment, net		24,647			28,880			22,360			23,508
Accounts receivable, net of current portion		—			143			57			115
Deferred tax assets		1,704			1,150			108			101
Goodwill		50,177			50,177			50,177			50,177
Intangible assets, net		32,661			35,844			29,615			31,144
Other assets		7,435			6,038			8,552			8,648
Total assets	$	470,241		$	492,966		$	421,518		$	468,707
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	22,841		$	41,203		$	14,031		$	28,087
Accrued expenses and other current liabilities		33,368			39,793			27,507			41,382
Accrued income taxes		4,020			7,463			11,320			4,991
Deferred revenue		15,857			15,531			19,139			14,473
Current portion of long-term debt, net of unamortized debt issuance costs		8,421			15,171			1,927			1,924
Total current liabilities		84,507			119,161			73,924			90,857
Accrued income taxes, net of current portion		11,359			9,520			10,389			7,732
Deferred tax liabilities		6,504			7,282			5,666			5,293
Deferred revenue, net of current portion		5,072			3,520			6,474			7,012
Long-term debt, net of current portion and unamortized debt issuance costs		274,672			276,085			273,710			274,193
Other liabilities, net of current portion		1,582			1,024			1,774			1,701
Total liabilities		383,696			416,592			371,937			386,788
Commitments and contingencies (Note 17)
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000 shares authorized as of September 30, 2021 and December 31, 2020; 0shares issued and outstanding as of September 30, 2021 and December 31, 2020		—			—
Common stock, $0.001 par value; 500,000 shares authorized; 87,678 and 85,329 shares issued as of September 30, 2021 and December 31, 2020, respectively; 85,956 and 83,607 shares outstanding as of September 30, 2021 and December 31, 2020, respectively		88			85
Treasury stock, at cost; 1,722 shares		(4,826	)		(4,826	)
Preferred stock, $0.001 par value; 5,000 shares authorized as of March 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021								—			—
Common stock, $0.001 par value; 500,000 shares authorized; 88,452 and 87,815 shares issued as of March 31, 2022 and December 31, 2021, respectively; 84,855 and 84,422 shares outstanding as of March 31, 2022 and December 31, 2021, respectively								88			88
Treasury stock, at cost; 3,597 and 3,393 shares as of March 31, 2022 and December 31, 2021, respectively								(14,837	)		(13,645	)
Additional paid-in capital		191,399			183,041			194,973			193,654
Accumulated other comprehensive income		467			337			997			878
Accumulated deficit		(100,583	)		(102,263	)		(131,640	)		(99,056	)
Total stockholders’ equity		86,545			76,374			49,581			81,919
Total liabilities and stockholders’ equity	$	470,241		$	492,966		$	421,518		$	468,707

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2021			2020			2022			2021
Revenue:
Product	$	87,752		$	93,741		$	262,019		$	239,627		$	52,545		$	93,798
Service		11,467			12,006			34,207			33,093			11,854			10,479
Total revenue		99,219			105,747			296,226			272,720			64,399			104,277
Cost of revenue:
Product		57,372			51,947			150,515			130,602			36,228			47,026
Service		1,223			1,206			3,532			3,741			1,492			1,211
Total cost of revenue		58,595			53,153			154,047			134,343			37,720			48,237
Gross profit		40,624			52,594			142,179			138,377			26,679			56,040
Operating expenses:
Research and development		21,578			21,823			63,479			63,722			22,673			21,606
Selling, general and administrative		21,029			21,630			64,492			67,731			22,329			21,880
Total operating expenses		42,607			43,453			127,971			131,453			45,002			43,486
(Loss) income from operations		(1,983	)		9,141			14,208			6,924			(18,323	)		12,554
Other income (expense):
Interest income		80			170			297			847			34			114
Interest expense		(3,969	)		(3,771	)		(11,886	)		(12,706	)		(3,688	)		(3,918	)
(Loss) gain on foreign currency, net		(375	)		(6	)		(1,353	)		674
Loss on foreign currency, net														(273	)		(747	)
Other income, net		83			338			634			435			18			72
Total other income (expense), net		(4,181	)		(3,269	)		(12,308	)		(10,750	)		(3,909	)		(4,479	)
(Loss) income before (benefit from) provision for income taxes		(6,164	)		5,872			1,900			(3,826	)
(Benefit from) provision for income taxes		(5,288	)		2,399			220			(5,433	)
(Loss) income before provision for income taxes														(22,232	)		8,075
Provision for income taxes														10,352			2,326
Net (loss) income		(876	)		3,473			1,680			1,607			(32,584	)		5,749
Other comprehensive (loss) income—foreign currency translation adjustment, net of tax		(127	)		1,334			130			916
Other comprehensive loss—gain on foreign currency hedge net of tax		—			(527	)		—			—
Other comprehensive income (loss) —foreign currency translation adjustment, net of tax														119			(336	)
Comprehensive (loss) income	$	(1,003	)	$	4,280		$	1,810		$	2,523		$	(32,465	)	$	5,413
Net (loss) income per share attributable to common stockholders:
Basic	$	(0.01	)	$	0.04		$	0.02		$	0.02		$	(0.39	)	$	0.07
Diluted	$	(0.01	)	$	0.04		$	0.02		$	0.02		$	(0.39	)	$	0.06
Weighted-average shares used to compute net (loss) income per share attributable to common stockholders:
Basic		85,660			83,302			84,985			83,437			84,583			84,242
Diluted		85,660			85,466			88,948			85,370			84,583			88,568

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

	Common Stock				Treasury Stock					Additional Paid-in		Accumulated Other Comprehensive			Accumulated			Total Stockholders’			Common Stock				Treasury Stock					Additional Paid-in			Accumulated Other Comprehensive		Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount			Capital		Income			Deficit			Equity			Shares		Amount		Shares		Amount			Capital			Income		Deficit			Equity
Balances at June 30, 2021		87,116	$	87		1,722	$	(4,826	)	$	185,809	$	594		$	(99,707	)	$	81,957
Balances at January 1, 2022																						87,815	$	88		3,393	$	(13,645	)	$	193,654		$	878	$	(99,056	)	$	81,919
Exercise of stock options and common stock issued upon vesting of equity awards, net of shares withheld for employee taxes		562		1		—		—			1,704		—			—			1,705			637		—		—		—			(1,412	)		—		—			(1,412	)
Foreign currency translation adjustment		—		—		—		—			—		(127	)		—			(127	)		—		—		—		—			—			119		—			119
Repurchases of treasury shares																						—		—		204		(1,192	)		—			—		—			(1,192	)
Stock-based compensation		—		—		—		—			3,886		—			—			3,886			—		—		—		—			2,731			—		—			2,731
Net loss		—		—		—		—			—		—			(876	)		(876	)		—		—		—		—			—			—		(32,584	)		(32,584	)
Balances at September 30, 2021		87,678	$	88		1,722	$	(4,826	)	$	191,399	$	467		$	(100,583	)	$	86,545
Balances at March 31, 2022																						88,452	$	88		3,597	$	(14,837	)	$	194,973		$	997	$	(131,640	)	$	49,581

	Common Stock				Treasury Stock					Additional Paid-in			Accumulated Other Comprehensive			Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount			Capital			Income			Deficit			Equity
Balances at January 1, 2021		85,329	$	85		1,722	$	(4,826	)	$	183,041		$	337		$	(102,263	)	$	76,374
Exercise of stock options and common stock issued upon vesting of equity awards, net of shares withheld for employee taxes		1,173		1		—		—			(4,058	)		—			—			(4,057	)
Foreign currency translation adjustment		—		—		—		—			—			(336	)		—			(336	)
Stock-based compensation		—		—		—		—			3,105			—			—			3,105
Net income		—		—		—		—			—			—			5,749			5,749
Balances at March 31, 2021		86,502	$	86		1,722	$	(4,826	)	$	182,088		$	1		$	(96,514	)	$	80,835

Common Stock

Treasury Stock

Additional
Paid-in

Accumulated
Other
Comprehensive

Accumulated

Total
Stockholders’

Shares

Amount

Shares

Amount

Capital

Income

Deficit

Equity

Balances at January 1, 2021

85,329

$
85

1,722

$
(4,826
)

$
183,041

$
337

$
(102,263
)

$
76,374

Exercise of stock options and common stock
issued upon vesting of equity awards, net
of shares withheld for employee taxes

2,349

3

—

—

(2,787
)

—

—

(2,784
)
Foreign currency translation adjustment

—

—

—

—

—

130

—

130

Stock-based compensation

—

—

—

—

11,145

—

—

11,145

Net income

—

—

—

—

—

—

1,680

1,680

Balances at September 30, 2021

87,678

$
88

1,722

$
(4,826
)

$
191,399

$
467

$
(100,583
)

$
86,545

~~The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.~~

Common Stock

Treasury Stock

Additional
Paid-in

Accumulated
Other
Comprehensive

Accumulated

Total
Stockholders’

Shares

Amount

Shares

Amount

Capital

Loss

Deficit

Equity

Balances at June 30, 2020

84,856

$
85

1,722

$
(4,826
)

$
175,496

$
(2,113
)

$
(128,930
)

$
39,712

Exercise of stock options and common
   stock issued upon vesting of equity
   awards, net of shares withheld for
   employee taxes

389

—

—

—

390

—

—

390

Cash flow hedges

—

—

—

—

—

(527
)

—

(527
)
Foreign currency translation adjustment

—

—

—

—

—

1,334

—

1,334

Stock-based compensation

—

—

—

—

3,496

—

—

3,496

Net income

—

—

—

—

—

—

3,473

3,473

Balances at September 30, 2020

85,245

$
85

1,722

$
(4,826
)

$
179,382

$
(1,306
)

$
(125,457
)

$
47,878

Common Stock

Treasury Stock

Additional
Paid-in

Accumulated
Other
Comprehensive

Accumulated

Total
Stockholders’

Shares

Amount

Shares

Amount

Capital

Loss

Deficit

Equity

Balances at January 1, 2020

84,333

$
84

495

$
(1,795
)

$
169,561

$
(2,222
)

$
(127,064
)

$
38,564

Exercise of stock options and common
   stock issued upon vesting of equity
   awards, net of shares withheld for
   employee taxes

912

1

—

—

316

—

—

317

Foreign currency translation adjustment

—

—

—

—

—

916

—

916

Repurchases of treasury shares

—

—

1,227

(3,031
)

—

—

—

(3,031
)
Stock-based compensation

—

—

—

—

9,505

—

—

9,505

Net income

—

—

—

—

—

—

1,607

1,607

Balances at September 30, 2020

85,245

$
85

1,722

$
(4,826
)

$
179,382

$
(1,306
)

$
(125,457
)

$
47,878

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

	Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2022			2021
Cash flows provided by operating activities:
Net income	$	1,680		$	1,607
Adjustments to reconcile net income to net cash provided by operating activities:
Operating activities:
Net (loss) income							$	(32,584	)	$	5,749
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation and amortization		11,986			13,660			3,615			4,209
Stock-based compensation		11,245			9,498			2,628			3,453
Deferred income taxes		(1,322	)		(1,834	)		369			138
Increase in provision for doubtful accounts		63			18			253			91
Change in provision for excess and obsolete inventory		(98	)		1,290			(27	)		113
Gain on disposal of assets		29			11
Changes in operating assets and liabilities:
Accounts receivable		13,194			27,537			37,487			469
Inventory		9,302			(6,617	)		(514	)		4,558
Prepaid expenses and other assets		(1,648	)		3,004			(205	)		(5,834	)
Prepaid income taxes		(5,873	)		(9,763	)		21,333			(680	)
Accounts payable		(17,553	)		13,764			(13,661	)		(15,607	)
Accrued expenses and other current liabilities		(6,074	)		973			(13,707	)		(10,118	)
Accrued income taxes		(1,601	)		2,467			8,985			2,225
Deferred revenue		1,867			(3,971	)		4,125			6,079
Net cash provided by operating activities		15,197			51,644
Cash flows used in investing activities:
Net cash provided by (used in) operating activities								18,097			(5,155	)
Investing activities:
Purchases of property and equipment		(2,979	)		(4,102	)		(962	)		(852	)
Purchases of software licenses		(1,425	)		—			(4	)		(1,400	)
Net cash used in investing activities		(4,404	)		(4,102	)		(966	)		(2,252	)
Cash flows used in financing activities:
Financing activities:
Principal repayments of debt		(9,025	)		(8,893	)		(750	)		(750	)
Borrowings on revolving credit facility		—			6,500
Proceeds from exercise of stock options		3,532			957			79			574
Employee taxes paid related to net share settlement of equity awards		(6,315	)		(639	)		(1,490	)		(4,630	)
Payments of dividends and equitable adjustments		(97	)		(661	)		(1	)		(13	)
Repurchases of treasury stock		—			(3,031	)
Repurchases of common stock								(1,192	)		—
Net cash used in financing activities		(11,905	)		(5,767	)		(3,354	)		(4,819	)
Effect of exchange rate changes on cash and cash equivalents		111			763			100			(266	)
Net (decrease) increase in cash, cash equivalents and restricted cash		(1,001	)		42,538
Net increase (decrease) in cash, cash equivalents and restricted cash								13,877			(12,492	)
Cash, cash equivalents and restricted cash at beginning of period		158,461			114,657			157,804			158,461
Cash, cash equivalents and restricted cash at end of period ⁽¹⁾	$	157,460		$	157,195		$	171,681		$	145,969
Supplemental disclosures of cash flow information:
Cash paid for interest	$	12,167		$	9,226		$	3,478		$	3,682
Cash paid for income taxes	$	8,288		$	2,306		$	1,806		$	290
Supplemental disclosures of non-cash operating, investing and financing activities:
Purchases of property and equipment included in accounts payable	$	179		$	673		$	60		$	325
Unpaid equitable adjustments included in accrued expenses and other current liabilities	$	1		$	85		$	—		$	50
Release of customer incentives included in accounts receivable and accrued expenses and other current liabilities							$	—		$	1,076

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Casa Systems, Inc. (the “Company”) was incorporated under the laws of the State of Delaware on February 28, 2003. The Company is a global communications technology company headquartered in Andover, Massachusetts and has wholly owned subsidiaries in China, France, Canada, Ireland, Spain, Colombia, the Netherlands, Hong Kong, Australia, Germany, the United Kingdom and New Zealand.

The Company offers physical, virtual and cloud-native 5G ~~broadband~~infrastructure and customer premise networking equipment ~~for~~solutions to help CSPs transform and expand their public and private high-speed data and multi-service communications ~~networks.~~networks so they can meet the growing demand for bandwidth and new services. The Company’s core and edge broadband technology enables ~~communications service providers~~CSPs and enterprises to cost-effectively and dynamically increase data network speed, add bandwidth capacity and new services, reduce network complexity and reduce operating and capital ~~expenditures.~~ expenditures regardless of access technology.

The Company is subject to a number of risks similar to other companies of comparable size and other companies selling and providing services to the ~~communications service provider (“CSP”)~~CSP industry. These risks include, but are not limited to, the level of capital spending by ~~the~~ CSPs, a lengthy sales cycle, dependence on the development of new products and services, unfavorable economic and market conditions, competition from larger and more established companies, limited management resources, dependence on a limited number of contract manufacturers and suppliers, the rapidly changing nature of the technology used by ~~the~~ CSPs and reliance on resellers and sales agents. Failure by the Company to anticipate or to respond adequately to technological developments in its industry, changes in customer or supplier requirements, changes in regulatory requirements or industry standards, or any significant delays in the development or introduction of products could have a material adverse effect on the Company’s operating results, financial condition and cash flows.

The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and may remain an emerging growth company until the last day of the fiscal year following the fifth anniversary of the Company’s initial public offering, subject to specified conditions. The JOBS Act provides that an emerging growth company can take advantage of the extended transition period afforded by the JOBS Act for the implementation of new or revised accounting standards. The Company has elected not to “opt out” of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company is required to adopt the new or revised standard at or prior to the time private companies are required to adopt the new or revised standard, provided that the Company continues to be an emerging growth company. The JOBS Act provides that the decision to take advantage of the extended transition period for complying with new or revised accounting standards is irrevocable.

The accompanying condensed consolidated balance sheet as of ~~September 30, 2021,~~March 31, 2022, the condensed consolidated statements of operations and comprehensive (loss) income for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the condensed consolidated statements of cash flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ and the condensed consolidated statements of stockholders’ equity for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ are unaudited. The financial data and other information disclosed in these notes related to the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ are also unaudited. The accompanying condensed consolidated balance sheet as of December 31, ~~2020~~2021 was derived from the Company’s audited consolidated financial statements for the year ended December 31, ~~2020~~2021 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 25, ~~2021~~2022 (the “Annual Report on Form 10-K”). The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted ~~accounting principles~~ in the United States of America (“GAAP”) regarding interim financial reporting. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Annual Report on Form 10-K. There have been no changes to the Company’s accounting policies from those disclosed in the Annual Report on Form 10-K that would have a material impact on the Company’s condensed consolidated financial statements.

The unaudited interim condensed consolidated financial statements have been prepared on a basis consistent with that used to prepare the audited annual consolidated financial statements and, in the opinion of management, include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations and cash flows to be anticipated for the full year ending December 31, ~~2021~~2022 or any future period.

The accompanying condensed consolidated financial statements include the accounts and results of operations of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods.

Significant estimates and judgments relied upon by management in preparing these condensed consolidated financial statements include revenue recognition, ~~provision for doubtful accounts,~~ reserves for excess and obsolete inventory, valuation of inventory and deferred inventory costs, the expensing and capitalization of software-related research and development costs, amortization and depreciation periods, the recoverability of net deferred tax assets, valuations of uncertain tax positions, warranty allowances, the valuation of equity instruments and stock-based compensation expense.

Although the Company regularly reassesses the assumptions underlying these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances existing at the time such estimates are made.

The COVID-19 pandemic presents various risks to the Company, ~~not all of which the Company is able to fully evaluate or even to foresee at the current time, and~~ which could continue to have a material effect upon the estimates and judgments relied upon by management in preparing these condensed consolidated financial statements. While the Company remains fully operational, during the three ~~and nine~~ months ended ~~September 30, 2021,~~March 31, 2022, the effects of the COVID-19 pandemic on the global supply chain had a significant adverse effect on the Company’s financial results. In particular, certain of the Company’s products utilize components, ~~for which there has been increased~~whose availability was significantly exceeded by global demand. As a result, ~~throughout 2021, and increasingly~~ during the three months ended ~~September 30, 2021,~~March 31, 2022, the Company ~~began~~continued to see shortages of supply that resulted in the Company’s inability to fulfill certain customer orders within normal lead times. This adversely impacted the Company’s revenue and operating results for the three ~~and nine~~ months ended ~~September 30, 2021.~~March 31, 2022. Additionally, shipping bottlenecks and delays negatively affected the Company’s ability to timely fulfill customer orders, thereby delaying its ability to consummate sales and recognize revenue. The Company also experienced, in some cases, significant increases in shipping costs. While the Company continues to work with its supply chain, contract manufacturers, logistics partners, and customers to minimize the extent of such impacts, the Company expects the effects of global supply chain issues to continue and cannot predict when such effects will subside. This may prevent the Company from being able to fulfill its customers’ orders in a timely manner or at all, which could lead to one or more of its customers cancelling their orders. At this time the Company is neither able to estimate the extent of these impacts nor predict whether its efforts to minimize or contain them will be successful. The Company intends to continue to monitor its business very closely for any effects of COVID-19 for as long as necessary.

The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated as required. Other than the agreement with Verizon Ventures LLC, as discussed in Note 17, Subsequent Events, the Company has evaluated all subsequent events and determined that there are no additional material recognized or unrecognized subsequent events requiring disclosure in these condensed consolidated financial statements.

Cash and cash equivalents include all highly liquid investments maturing within three months from the date of purchase. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company’s cash and cash equivalents consisted of investments in ~~certificates of deposit and~~ money market mutual funds.

Restricted cash as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consisted of a certificate of deposit of ~~$1,000 and $1,006, respectively,~~$1,001, pledged as collateral for a stand-by letter of credit required to support a contractual obligation. Restricted cash also included cash of $2,100 pledged as collateral in connection with five and two letters of credit to support contractual obligations at March 31, 2022 and December 31, 2021, respectively.

The following table is a reconciliation of cash, cash equivalents and restricted cash included in the accompanying condensed consolidated balance sheets that sum to the total cash, cash equivalents and restricted cash included in the accompanying condensed consolidated statements of cash flows:

Accounts receivable are presented net of a provision for doubtful accounts, which is an estimate of amounts that may not be collectible. Accounts receivable for customer contracts with customary payment terms, which are one year or less, are recorded at invoiced amounts and do not bear interest. The Company may, in limited circumstances, grant payment terms longer than one year. Payments due beyond 12 months from the balance sheet date are recorded as non-current assets. The Company generally does not require collateral, but the Company may, in certain instances based on its credit assessment, require full or partial prepayment prior to shipment.

Accounts receivable as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consisted of the following:

	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Current portion of accounts receivable, net:
Accounts receivable, net	$	80,719	$	93,480	$	48,029	$	85,689
Accounts receivable, extended payment terms		144		644		77		85
		80,863		94,124		48,106		85,774
Accounts receivable, net of current portion:
Accounts receivable, extended payment terms		—		143		57		115
	$	80,863	$	94,267	$	48,163	$	85,889

The Company performs ongoing credit evaluations of its customers and, if necessary, provides a provision for doubtful accounts and expected losses. When assessing and recording its provision for doubtful accounts, the Company evaluates the age of its accounts receivable, current economic trends, creditworthiness of the customer, customer payment history, and other specific customer and transaction information. The Company writes off accounts receivable against the provision when it determines a balance is uncollectible and no longer actively pursues collection of the receivable. Adjustments to the provision for doubtful accounts are recorded as selling, general and administrative expenses in the condensed consolidated statements of operations and comprehensive (loss) income.

As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company concluded that all amounts due under extended payment terms were collectible and 0 reserve for credit losses was recorded. During the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the Company did 0t provide a reserve for credit losses and did 0t write off any uncollectible receivables due under extended payment terms.

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. Cash and cash equivalents consist of demand deposits, savings accounts, money market mutual funds, and certificates of deposit with financial institutions, which may exceed Federal Deposit Insurance Corporation limits. The Company has not experienced any losses related to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.

The Company grants credit to customers in the ordinary course of business. Credit evaluations are performed on an ongoing basis to reduce credit risk, and no collateral is required from the Company’s customers. An allowance for uncollectible accounts is provided for those accounts receivable considered to be uncollectible based upon historical experience and credit evaluation. Due to these factors, no additional losses beyond the amounts provided for collection losses is believed by management to be probable in the Company’s accounts receivable.

Significant customers are those that represent 10% or more of revenue or accounts receivable and are set forth in the following tables:

	Revenue						Revenue						Revenue						Accounts Receivable, Net
	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,						As of	As of
	2021			2020			2021			2020			2022			2021			March 31, 2022	December 31, 2021
Customer A		24	%		13	%		20	%	*				14	%	*			*	*
Customer B	*				27	%	*				23	%		10	%	*			*	*
Customer C	*			*				11	%	*				10	%	*			*	*
Customer D													*				19	%	*		21	%
Customer E													*				18	%	*	*
Customer F													*			*			*		19	%
Customer G													*			*			*		10	%

Certain of the components and subassemblies included in the Company’s products are obtained and manufactured from a single source or a limited group of suppliers. Although the Company seeks to reduce dependence on those single or limited source suppliers, the partial or complete loss of certain of these sources could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.

The Company measures stock options and other stock-based awards granted to employees and directors based on the fair value on the date of grant and recognizes compensation expense of those awards, net of estimated forfeitures, over the requisite service period, which is generally the vesting period of the respective award. Generally, the Company issues stock options with only service-based vesting conditions and records the expense for these awards using the straight-line method.

The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive (loss) income in the same manner in which the award recipient’s payroll costs are classified or in which the award recipient’s service payments are classified.

The Company recognizes compensation expense for only the portion of awards that are expected to vest. In developing a forfeiture rate estimate, the Company has considered its historical experience to estimate pre-vesting forfeitures for service-based awards. The impact of a forfeiture rate adjustment will be recognized in full in the period of adjustment, and if the actual forfeiture rate is materially different from the Company’s estimate, the Company may be required to record adjustments to stock-based compensation expense in future periods.

The Company estimates the fair value of each stock option grant on the date of grant using the Black-Scholes option pricing model. The Company was a private company until December 14, 2017 and lacks sufficient company-specific historical and implied volatility information for its stock. Therefore, for all options granted in 2020 or before, the Company estimated its expected stock volatility based on the historical volatility of publicly traded peer companies. Beginning with options granted in 2021, the Company estimates its expected stock volatility using a weighted-average calculation based on the historical volatility of the Company and publicly traded peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company’s stock options has been determined utilizing the “simplified” method for awards that qualify as “plain-vanilla” options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company does not have a history of declaring or paying cash dividends, except for the special cash dividends declared in November 2014, June 2016, December 2016, May 2017 and November 2017, and in those circumstances the board of directors approved cash dividends to be paid to holders of the Company’s stock options, stock appreciation rights (“SARs”) and restricted stock units (“RSUs”) upon vesting as an equitable adjustment to the holders of such instruments.

The Company has also granted SARs to certain employees, which require the Company to pay in cash upon exercise an amount equal to the product of the excess of the per share fair market value of the Company’s common stock on the date of exercise over the exercise price, multiplied by the number of shares of common stock with respect to which the SAR is exercised. Because these awards may require the Company to settle the awards in cash, the Company accounts for them as a liability in the Company’s consolidated balance sheets. The Company recognizes the liability related to these awards, as well as related compensation expense over the period during which services are rendered until completed. As all SARs are now fully vested, the Company continues to remeasure the fair market value of the liability until the award is either exercised or canceled, with changes in the fair value of the liability recorded in the consolidated statements of operations and comprehensive (loss) income.

In ~~August 2020,~~October 2021, the Financial Accounting Standards Board, or FASB, issued ~~ASU 2020-06,~~Accounting Standards Codification Update (“ASU”) 2021-08, ~~Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)~~Business Combinations (Topic 805): Accounting for ~~Convertible Instruments~~Contract Assets and Contract Liabilities from Contracts with Customers, or ASU 2021-08. Under ASU 2021-08, an acquirer must recognize and measure contract assets and contract liabilities acquired in ~~an Entity’s Own Equity. This guidance simplifies~~a business combination in accordance with Topic 606. Effective January 1, 2022, the ~~guidance~~Company early adopted ASU 2021-08 on ~~certain financial instruments with characteristics~~a prospective basis. The impact of liability and equity, including convertible debt instruments. As a result, entities will not separately present in equity an embedded conversion feature in such debt and will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The eliminationadoption of these models will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that is within the scope of ASU 2020-06. The ASU also simplifies the diluted earnings per share calculation in certain areas. The guidance will become effective for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company has elected to early adopt this ~~ASU and the adoption did not have a material impact~~standard on the Company’s condensed consolidated financial statements ~~and the accompanying notes thereto.~~was not material.

In February 2016, the FASB, issued ASU 2016-02, Leases (Topic 842): Amendments to FASB Accounting Standards Codification(“, or ASU ~~2016-02”),~~2016-02, which replaces the existing guidance for leases. ASU 2016-02 requires the identification of arrangements that should be accounted for as leases by lessees. In general, for lease arrangements exceeding a twelve-month term, the arrangements must now be recognized as assets and liabilities on the balance sheet of the lessee. Under ASU 2016-02, a right-of-use asset and lease obligation will be recorded for all leases, whether operating or financing, while the income statement will reflect lease expense for operating leases and amortization/interest expense for financing leases. The balance sheet amount recorded for existing leases at the date of adoption of ASU 2016-02 must be calculated using the applicable incremental borrowing rate at the date of adoption. This guidance will become effective for private companies, and emerging growth companies that choose to take advantage of the extended transition periods, for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The Company has begun planning for adoption by implementing a new lease accounting software and by working to establish additional changes to internal processes to comply with all requirements upon adoption. The standard allows for, and the Company plans on using, a modified retrospective approach with comparatives under ASC 840, where entities would recognize a cumulative effect to retained earnings at the date of adoption without restating prior period balances or disclosure. Management is continuing to assess the impact of ASU 2016-02 on the Company’s condensed consolidated financial statements and the accompanying notes thereto.

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (“, or ASU ~~2016-13”).~~2016-13. This guidance is intended to provide more decision-useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. The main provisions include presenting financial assets measured at amortized cost at the amount expected to be collected, which is net of an allowance for expected credit losses, and recording credit losses related to available-for-sale securities through an allowance for credit losses. The effective dates for the amendments in ASU 2016-13 were updated in ASU 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), and as such ASU 2016-13 will become effective for private companies, and emerging growth companies that choose to take advantage of the extended transition periods, for fiscal years beginning after December 15, 2022, including interim periods within those fiscal periods, and must be applied

using a modified retrospective approach. The Company is currently evaluating the impact ASU 2016-13 will have on its consolidated financial statements.

Other than the disclosures above, there have been no changes to the significant accounting policies disclosed in Note 2 “Summary of Significant Accounting Policies” to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, ~~2020.~~2021.

Intangible assets, net consisted of intangible assets resulting from the acquisition of NetComm and purchased software to be used in the Company’s products. Intangible assets, net consisted of the following at ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, respectively:

	Cost		Accumulated Amortization			Net Balance		Cost		Accumulated Amortization			Net Balance
Developed Technology	$	25,000	$	(8,037	)	$	16,963	$	25,000	$	(9,823	)	$	15,177
Customer Relationships		18,000		(4,050	)		13,950		18,000		(4,950	)		13,050
Trade Name		1,000		(747	)		253		1,000		(917	)		83
Purchased software		1,817		(322	)		1,495		1,836		(531	)		1,305
Totals as of September 30, 2021	$	45,817	$	(13,156	)	$	32,661
Totals as of March 31, 2022								$	45,836	$	(16,221	)	$	29,615

	Cost		Accumulated Amortization			Net Balance		Cost		Accumulated Amortization			Net Balance
Developed Technology	$	25,000	$	(5,358	)	$	19,642	$	25,000	$	(8,930	)	$	16,070
Customer Relationships		18,000		(2,700	)		15,300		18,000		(4,500	)		13,500
Trade Name		1,000		(498	)		502		1,000		(830	)		170
Purchased software		432		(32	)		400		1,832		(428	)		1,404
Totals as of December 31, 2020	$	44,432	$	(8,588	)	$	35,844
Totals as of December 31, 2021								$	45,832	$	(14,688	)	$	31,144

As of ~~September 30, 2021,~~March 31, 2022, amortization expense on existing intangible assets for the next five years and beyond is as follows:

Year Ending December 31,
Remainder of 2021	$	1,532
2022		5,958
Remainder of 2022			$	4,430
2023		5,760		5,766
2024		5,656		5,662
2025		5,651		5,651
2026				3,606
Thereafter		8,104		4,500
	$	32,661	$	29,615

A summary of amortization expense recorded during the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Product cost of revenue	$	893	$	893	$	2,679	$	2,679	$	893	$	893
Research and development		105		—		290		—		103		82
Selling, general and administrative		533		533		1,599		1,600		537		533
Totals	$	1,531	$	1,426	$	4,568	$	4,279	$	1,533	$	1,508

The Company’s goodwill is the result of its acquisition of NetComm on July 1, 2019 and represents the excess of purchase price over the estimated fair value of net assets acquired. There has been no change to the $50,177 carrying amount of goodwill since December 31, ~~2020.~~

Inventory as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consisted of the following:

	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Raw materials	$	49,297	$	50,904	$	59,467	$	53,934
Work in process		—		19
Finished goods:
Manufactured finished goods		41,730		49,764		24,995		29,597
Deferred inventory costs		826		517		822		1,297
	$	91,853	$	101,204	$	85,284	$	84,828

Property and equipment as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consisted of the following:

	September 30, 2021			December 31, 2020			March 31, 2022			December 31, 2021
Computers and purchased software	$	25,284		$	24,865		$	25,585		$	25,775
Leasehold improvements		4,185			4,148			4,260			4,198
Furniture and fixtures		2,670			2,644			2,673			2,672
Machinery and equipment		37,427			36,701			36,295			37,325
Land		3,091			3,091			3,091			3,091
Building		4,765			4,765			4,765			4,765
Building improvements		7,282			7,244			7,285			7,291
Trial systems at customers’ sites		4,232			5,300			3,384			3,848
		88,936			88,758			87,338			88,965
Less: Accumulated depreciation and amortization		(64,289	)		(59,878	)		(64,978	)		(65,457	)
	$	24,647		$	28,880		$	22,360		$	23,508

During the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the Company transferred trial systems into inventory from property and equipment with values of ~~$1,145~~$464 and ~~$690,~~$661, respectively, net of transfers of trial systems to cost of revenue. In addition, the Company transferred ~~$325~~$662 and ~~$766~~$23 of equipment into inventory from property and equipment during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively.

Depreciation and amortization expense on property and equipment totaled ~~$2,258~~$2,082 and ~~$2,968~~$2,701 for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020, respectively, and $7,418 and $9,370 for the nine months ended September 30, 2021 and 2020,~~ respectively.

Accrued expenses and other current liabilities as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consisted of the following:

	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
Accrued compensation and related taxes	$	16,919	$	22,785	$	13,976	$	21,751
Accrued warranty						2,262		2,392
Inventory-related accruals		4,619		855		3,660		8,391
Accrued warranty		2,483		2,354
Other accrued expenses		9,347		13,799		7,609		8,848
	$	33,368	$	39,793	$	27,507	$	41,382

Substantially all of the Company’s products are covered by warranties for software and hardware for periods ranging from 90 days to one year. In addition, in conjunction with customers’ renewals of maintenance and support contracts, the Company offers an extended warranty for periods typically of one to three years for agreed-upon fees. In the event of a failure of a hardware product or software covered by these warranties, the Company must repair or replace the software or hardware or, if those remedies are insufficient, and at the discretion of the Company, provide a refund. The Company’s warranty reserve, which is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets, reflects estimated material, labor and other costs related to potential or actual software and hardware warranty claims for which the Company expects to incur an obligation. The Company’s estimates of anticipated rates of warranty claims and the costs associated therewith are primarily based on historical information and future forecasts. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary. If the historical data used to calculate the adequacy of the warranty reserve are not indicative of future requirements, additional or reduced warranty reserves may be required.

A summary of changes in the amount reserved for warranty costs for the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ is as follows:

	Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2022			2021
Warranty reserve at beginning of period	$	2,354		$	2,448		$	2,392		$	2,354
Provisions		2,015			2,054			387			866
Charges		(1,886	)		(2,103	)		(517	)		(757	)
Warranty reserve at end of period	$	2,483		$	2,399		$	2,262		$	2,463

The following tables present information about the fair value of the Company’s financial assets and liabilities as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 and indicate the level of the fair value hierarchy utilized to determine such fair values:

	Fair Value Measurements as of September 30, 2021 Using:								Fair Value Measurements as of March 31, 2022 Using:
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets:
Certificates of deposit—restricted cash	$	—	$	1,000	$	—	$	1,000	$	—	$	1,001	$	—	$	1,001
Money market mutual funds		127,221		—		—		127,221		135,084		—		—		135,084
Foreign currency forward contracts		—		24		—		24
	$	127,221	$	1,024	$	—	$	128,245	$	135,084	$	1,001	$	—	$	136,085
Liabilities:
SARs	$	—	$	—	$	458	$	458
Stock Appreciation Rights ("SARs")									$	—	$	—	$	255	$	255
	$	—	$	—	$	458	$	458	$	—	$	—	$	255	$	255

	Fair Value Measurements as of December 31, 2020 Using:								Fair Value Measurements as of December 31, 2021 Using:
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets:
Certificates of deposit—restricted cash	$	—	$	1,006	$	—	$	1,006	$	—	$	1,001	$	—	$	1,001
Money market mutual funds		114,404		—		—		114,404		93,792		—		—		93,792
Foreign currency forward contract									$	—		5		—		5
	$	114,404	$	1,006	$	—	$	115,410	$	93,792	$	1,006	$	—	$	94,798
Liabilities:
SARs	$	—	$	—	$	493	$	493	$	—	$	—	$	358	$	358
	$	—	$	—	$	493	$	493	$	—	$	—	$	358	$	358

During the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ there were 0 transfers between Level 1, Level 2 and Level 3.

There were no changes to the valuation techniques used to measure asset and liability fair values on a recurring basis during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 from those included in the Company’s consolidated financial statements for the year ended December 31, ~~2020.~~2021. The following table provides a summary of changes in the fair values of the Company’s SARs liability, for which fair value is determined by Level 3 inputs:

	Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2022			2021
Fair value at beginning of period	$	493		$	264		$	358		$	493
Change in fair value		100			(7	)		(103	)		347
Exercises		(135	)		—			—			(135	)
Fair value at end of period	$	458		$	257		$	255		$	705

The Company has certain international customers that are billed in foreign currencies. To mitigate the volatility related to fluctuations in the foreign exchange rates for accounts receivable denominated in foreign currencies, the Company enters into foreign currency forward contracts. As of September 30, 2021, the Company had foreign currency forward contracts outstanding with notional amounts totaling 1,379 Euros maturing in the fourth quarter of 2021 and the first quarter of 2022. As of December 31, 2020,~~0 foreign currency forward contracts were outstanding.~~

The Company’s foreign currency forward contracts described above economically hedged certain risks but were not designated as hedges for financial reporting purposes, and accordingly, all changes in the fair value of the derivative instruments were recorded as unrealized foreign currency transaction gains or losses and were included in the condensed consolidated statements of operations and comprehensive (loss) income as a component of other income (expense). The Company records derivative instruments in the condensed consolidated balance sheet at their fair values. As of September 30, 2021, the Company recorded an asset of $24relating to outstanding foreign currency forward contracts. As of December 31, 2020 the Company recorded 0 asset relating to outstanding foreign currency forward contracts. As of September 30, 2021 and December 31, 2020, the Company recorded 0 liability relating to outstanding foreign currency forward contracts.

The Company also faces exposure to foreign currency exchange rate fluctuations, as a certain portion of its expenses are denominated in currencies other than U.S. dollars. In certain instances, the Company utilizes forward contracts to hedge against foreign currency fluctuations. These contracts are used to minimize foreign gains or losses, as the gains or losses on the derivative are intended to offset the losses or gains on the underlying exposure. The Company does not engage in foreign currency speculation.

The Company designed its foreign currency risk management strategy principally to mitigate the potential financial impact of changes in the value of transactions and balances denominated in foreign currencies resulting from changes in foreign currency exchange rates. The Company may enter into cash flow hedges that utilize foreign currency forward contracts to hedge specific forecasted transactions of its foreign subsidiaries with the goal of protecting its budgeted expenses against foreign currency exchange rate changes compared to its budgeted rates.

During the three months ended September 30, 2020, the Company settled one cash flow hedge with a notional amount of 5,000 AUD to hedge certain Australian dollar cash flows incurred during the period. The amount of gain reclassified from other comprehensive (loss) income for the three months ended September 30, 2020 was $527. The full amount of the fair value of the derivatives on the settlement date of $725 was recognized as $57 cost of goods sold, $353 research and development expense and $315 selling, general and administrative expense in the condensed consolidated statement of comprehensive (loss) income for the three months ended September 30, 2020.

~~During the~~ ~~nine months ended September 30, 2020~~, the Company settled two cash flow hedges with notional amounts of 8,500 AUD and 5,000 AUD to hedge certain Australian dollar cash flows incurred during the period. The amount of gain reclassified from other comprehensive (loss) income for the nine months ended September 30, 2020 was $752. The full amount of the fair value of the derivatives on the settlement date of $1,613 was recognized as $124 cost of goods sold, $890 research and development expense and $599 selling, general and administrative expense in the condensed consolidated statement of comprehensive (loss) income for the nine months ended September 30, 2020.

~~The Company did 0t have any cash flow hedges outstanding as of September 30, 2021 and December 31, 2020.~~

The Company’s effective income tax rate was ~~85.8%~~(46.6)% and ~~40.9%~~28.8% for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively. The ~~(benefit from)~~ provision for income taxes was ~~$(5,288)~~$10,352 and ~~$2,399~~$2,326 for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively. The change in the ~~(benefit from)~~ provision for income taxes was primarily due to a ~~discrete benefit~~new requirement to capitalize and amortize all research and experimentation expenditures for U.S. tax purposes, which became effective under the Tax Cuts and Jobs Act (“TCJA”) as of ~~($7,097) recorded~~January 1, 2022. This new requirement results in significant forecasted U.S. income tax for the ~~three months ended September 30, 2021 related to~~year and the corresponding deferred tax asset created is offset by a ~~change in estimate of the Company’s prior year net operating loss that is able to be carried back as part of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”).~~full valuation allowance. The change in the ~~(benefit from)~~ provision for income taxes was also impacted by changes in the jurisdictional mix of earnings period over period.

The Company’s effective income tax rate was 11.6% and 142.0% for the nine months ended September 30, 2021 and 2020, respectively. The provision for (benefit from) income taxes was $220 and $(5,433) for the nine months ended September 30, 2021 and 2020, respectively. The change in the provision for (benefit from) income taxes was primarily due to a discrete tax benefit of $ (9,310) recorded during the nine months ended September 30, 2020 associated with the enactment of the CARES Act, partially offset by a discrete benefit of ($7,097) recorded during the nine months ended September 30, 2021 associated with a change in estimate of the Company’s prior year net operating loss that is able to be carried back as part of the CARES Act. The change in the provision for (benefit from) income taxes was also impacted by changes in the jurisdictional mix of earnings period over period.

The (benefit from) provision for income taxes for the three and nine months ended September 30, 2021 and 2020 differed from the federal statutory rate primarily due to the geographical mix of earnings and related foreign tax rate differential, permanent differences, research and development tax credits, foreign tax credits, the valuation allowance maintained against certain deferred tax assets and withholding taxes.

~~The aggregate principal amount of debt outstanding as of September 30, 2021 and December 31, 2020 consisted of the following:~~

~~Current and non-current debt obligations reflected in the condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020 consisted of the following:~~

~~As of September 30, 2021, aggregate minimum future principal payments of the Company’s debt are summarized as follows:~~

On December 20, 2016, the Company entered into a credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, various lenders and JPMorgan Chase Bank, N.A. and Barclays Bank PLC providing for (i) a term loan facility of $300,000 (the “Term Loan”) and (ii) a revolving credit facility of up to $25,000 in revolving credit loans and letters of ~~credit.~~credit, which matured on December 20, 2021.

Current and non-current debt obligations reflected in the condensed consolidated balance sheets as of March 31, 2022 and December 31, 2021 consisted of the following:

As of ~~September 30, 2021~~March 31, 2022, aggregate minimum future principal payments of the Company’s debt are summarized as follows:

As of March 31, 2022 and December 31, ~~2020, $278,975~~2021, $277,475 and ~~$288,000~~$278,225 in principal amount, respectively, were outstanding under the term loan facility (the “Term Loan”). As of September 30, 2021 and December 31, 2020, the Company had outstanding borrowings under the revolving credit facility of $6,500, which were repaid in full on October 25, 2021 using cash and cash equivalents in the condensed consolidated balance sheets as of September 30, 2021. See Note 18, ~~Subsequent Events~~ below for further discussion. As of September 30, 2021 and December 31, 2020, the Company had also used $1,450 and $1,454 of available credit under the revolving credit facility for two stand-by letters of credit, one which serves as collateral to one of the Company’s customers pursuant to a contractual performance guarantee and one which serves as collateral for operating leases in Australia. In addition, the Company may, subject to certain conditions, including the consent of the administrative agent and the institutions providing such increases, increase the facilities by an unlimited amount so long as the Company is in compliance with specified leverage ratios, or otherwise by up to $70,000.Term Loan.

Borrowings under the ~~facilities~~Term Loan bear interest at a floating rate, which can be either a Eurodollar rate plus an applicable margin or, at the Company’s option, a base rate (defined as the highest of (x) the JPMorgan Chase, N.A. prime rate, (y) the federal funds effective rate, plus one-half percent (0.50%) per annum and (z) a one-month Eurodollar rate plus 1.00% per annum) plus an applicable margin. The applicable margin for borrowings under the ~~term loan facility~~Term Loan is 4.00% per annum for Eurodollar rate loans (subject to a 1.00% per annum interest rate floor) and 3.00% per annum for base rate loans. The ~~applicable margin for borrowings under the revolving credit facility is 1.75% per annum for Eurodollar~~interest rate ~~loans and 0.75% per annum for base rate loans, subject to reduction based on the Company’s maintaining specified net leverage ratios. The interest rates~~ payable under the ~~facilities are~~Term Loan is subject to an increase of 2.00% per annum during the continuance of any payment default.

For Eurodollar rate loans, the Company may select interest periods of one, three or six months or, with the consent of all relevant affected lenders, twelve months. Interest will be payable at the end of the selected interest period, but no less frequently than every three months within the selected interest period. Interest on any base rate loan is not set for any specified period and is payable quarterly. The Company has the right to convert Eurodollar rate loans into base rate loans and the right to convert base rate loans into Eurodollar rate loans at its option, subject, in the case of Eurodollar rate loans, to breakage costs if the conversion is effected prior to the end of the applicable interest period. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the interest rate on the Term Loans was 5.00% per annum, which was based on a one-month ~~and six-month~~ Eurodollar ~~rate, respectively,~~rates, at the applicable floor of 1.00% per annum plus the applicable margin of 4.00% per annum for Eurodollar rate loans. As of September 30, 2021, the interest rate on the revolving credit facility was 1.83% per annum, which was based on a one-month Eurodollar rate of 0.08% per annum plus the applicable margin of 1.75% per annum for Eurodollar rate loans. As of December 31, 2020, the interest rate on the revolving credit facility was 2.12% per annum, which was based on the six-month Eurodollar rate of 0.37% per annum plus the applicable margin of 1.75% per annum for Eurodollar rate loans.

Upon entering into the ~~term loan facility,~~Term Loan, the Company incurred debt issuance costs of $7,811, which were initially recorded as a reduction of the debt liability and are amortized to interest expense using the effective interest method from the issuance date of the Term Loan until the maturity date. The Company made principal payments of $750 during each of the three months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020, and $9,025 and $2,250 during the nine months ended September 30, 2021 and 2020, respectively,~~ under the ~~term loan facility. No principal payments were made under the revolving credit facility during the three and nine months ended September 30, 2021 and 2020.~~Term Loan. Interest expense for the Term Loan, ~~and revolving credit facility,~~ including the amortization of debt issuance costs, totaled ~~$3,870~~$3,777 and ~~$3,892~~$3,869 for the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020, respectively, and totaled $11,672 and $12,366 for the nine months ended September 30, 2021 and 2020, respectively.~~

The revolving credit facility also requires payment of quarterly commitment fees at a rate of 0.25% per annum on the difference between committed amounts and amounts actually borrowed under the facility and customary letter of credit fees. For each of the three months ended September 30, 2021 and 2020, interest expense related to the fee for the unused amount of the revolving credit facility totaled $11 and for the nine months ended September 30, 2021 and 2020, interest expense related to the fee for the unused amount of the revolving credit facility totaled $33 ~~and $41,~~ respectively.

The Term Loan matures on December 20, 2023 and ~~the revolving credit facility matures on December 20, 2021. The Term Loans are~~is subject to amortization in equal quarterly installments, which commenced on March 31, 2017, of principal in an annual aggregate amount equal to 1.0% of the original principal amount of the Term ~~Loans~~Loan of $300,000, with the remaining outstanding balance payable at the date of maturity.

Voluntary prepayments of principal amounts outstanding under the ~~term loan facility~~Term Loan are permitted at any time; however, if a prepayment of principal is made with respect to a Eurodollar loan on a date other than the last day of the applicable interest period, the Company is required to compensate the lenders for any funding losses and expenses incurred as a result of the prepayment. ~~Prior to the revolving credit facility maturity date, funds borrowed under the revolving credit facility may be borrowed, repaid and reborrowed, without premium or penalty.~~

In addition, the Company is required to make mandatory prepayments under the ~~facilities~~Term Loan with respect to (i) 100% of the net cash proceeds from certain asset dispositions (including casualty and condemnation events) by the Company or certain of its subsidiaries, subject to certain exceptions and reinvestment provisions, (ii) 100% of the net cash proceeds from the issuance or incurrence of any additional debt by the Company or certain of its subsidiaries, subject to certain exceptions, and (iii) 50% of the Company’s excess cash flow, as defined in the credit agreement, subject to reduction upon its achievement of specified performance targets. In accordance with these provisions, a mandatory early prepayment of $6,775 was paid by the Company on April 2, 2021. This amount was included in the current portion of long-term debt, net of unamortized debt issuance costs on the condensed consolidated balance sheet as of December 31, 2020.

The ~~facilities are~~Term Loan is secured by, among other things, a first priority security interest, subject to permitted liens, in substantially all of the Company’s assets and all of the assets of certain of its subsidiaries and a pledge of certain of the stock of certain of its subsidiaries, in each case subject to specified exceptions. The ~~facilities contain~~Term Loan contains customary affirmative and negative covenants, including certain restrictions, onsuch as the Company’s ability to pay dividends, ~~and with respect to~~certain of which are based upon the ~~revolving credit facility, a financial covenant requiring the Company to maintain a specified~~Company’s total net leverage ~~ratio in the event that on the last day of any fiscal quarter the Company has utilized more than 30% of its borrowing capacity under the facility.~~ratio. The Company was in compliance with all covenants as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020.~~

On July 1, 2015, the Company entered into a commercial mortgage loan agreement in the amount of $7,950 (the “Mortgage Loan”). Borrowings under the Mortgage Loan bore interest at a rate of 3.5% per annum and were repayable in 60 monthly installments of $46, consisting of principal and interest based on a 20-year amortization schedule. The remaining amount of unpaid principal under the Mortgage Loan was paid on the maturity date of July 1, 2020 utilizing the Company’s revolving credit facility. Upon entering into the Mortgage Loan, the Company incurred debt issuance cost of $45, which was initially recorded as a direct deduction from the debt liability and was amortized to interest expense using the effective interest method from the issuance date of the loan until the maturity date.

~~The Mortgage Loan was paid on the maturity date of July 1, 2020, utilizing the Company’s revolving credit facility. The Company made principal payments under the Mortgage Loan of~~$6,483 and $6,643 during the three and nine months ended September 30, 2020, respectively. NaN interest expense was incurred during the three months ended September 30, 2020. Interest expense, including the amortization of debt issuance costs, totaled $120 during the nine months ended September 30, 2020.2021.

In connection with special dividends previously declared, the board of directors also approved cash payments to be made to holders of the Company’s stock options, SARs and RSUs as equitable adjustments to the holders of such instruments in accordance with the provisions of the Company’s equity incentive plans. These equitable adjustment payments are equal to

an amount per share multiplied by the net number of shares subject to outstanding equity awards after applying the treasury stock method. The below table provides details of these equitable adjustment payments:

Equitable Adjustment Payments

Nine Months Ended

Equitable Adjustment Liability(1)

Dividend Declaration Dates

Equitable
Adjustment
per share

Year of Final
Vesting

September 30, 2021

September 30, 2020

As of September 30, 2021

As of December 31, 2020

November 30, 2017

$
0.5802

2021

$
42

$
136

$
1

$
30
��
May 10, 2017

1.1774

2021

53

176

—

31

December 27, 2016

2.3306

2020

2

295

—

2

June 17, 2016

0.5891

2020

—

54

—

—

Total

$
97

$
661

$
1

$
63

On February 21, 2019, the Company announced a stock repurchase program authorizing it to repurchase up to $75,000 of the Company’s common stock. The Company repurchased 205 shares, at a cost of $1,192, including commissions, during the three months ended March 31, 2022. There were 0 repurchases made during the three ~~and nine~~ months ended ~~September 30,~~March 31, 2021. There were 0 repurchases during the three months ended September 30, 2020. During the nine months ended September 30, 2020, the Company repurchased 1,227 shares, at a cost of $3,031, including commissions. As of ~~September 30, 2021, $70,208~~March 31, 2022, $60,234 remained authorized for repurchases of the Company’s common stock under the stock repurchase program. The stock repurchase program has no expiration date and does not require the Company to purchase a minimum number of shares, and the Company may suspend, modify or discontinue the stock repurchase program at any time without prior notice.

The Company’s 2017 Stock Incentive Plan (the “2017 Plan”) provides for the Company to sell or issue common stock or restricted common stock, or to grant qualified incentive stock options, nonqualified stock options, SARs, performance-based restricted stock units (“PSUs”), RSUs or other stock-based awards to the Company’s employees, officers, directors, advisors and outside consultants. The total number of shares authorized for issuance under the 2017 Plan was ~~20,617~~19,842 shares as of ~~September 30, 2021~~March 31, 2022, of which ~~9,755~~9,650 shares remained available for future grant.

~~The following table summarizes the outstanding~~A summary of stock option activity ~~and a summary of information related to stock options as of and~~ for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 is as follows:

Number
of
Shares

Weighted-
Average
Exercise
Price

Weighted-
Average
Remaining
Contractual
Term

Aggregate
Intrinsic
Value

(in years)

Outstanding at January 1, 2021

7,120

$
8.01

4.88

$
9,367

Granted

116

8.23

Exercised

(904
)

2.26

Forfeited

(292
)

10.70

Outstanding at September 30, 2021

6,040

$
8.74

4.53

$
7,200

Options exercisable at September 30, 2021

5,665

$
8.69

4.28

$
6,924

Vested or expected to vest at September 30, 2021

6,032

$
8.74

4.52

$
7,182

	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value
						(in years)
Outstanding at January 1, 2022		5,919		$	8.82		4.36	$	4,205
Granted		576			4.31
Exercised		(33	)		2.36
Forfeited		(68	)		9.35
Outstanding at March 31, 2022		6,394		$	8.44		4.60	$	1,708
Options exercisable at March 31, 2022		5,586		$	8.94		3.89	$	1,557
Vested or expected to vest at March 31, 2022		6,324		$	8.48		4.54	$	1,695

The fair value of each option is estimated on the date of grant using the Black-Scholes option-pricing model using the following assumptions:

	Three Months Ended September 30,		Nine Months Ended September 30,		Three Months Ended March 31,
	2021	2020	2021	2020	2022	2021
Risk-free interest rate	1.0%	0.4%	1.0%	0.4%-0.7%	1.7%–2.0%	0.4%
Expected term (in years)	6.1	6.1	6.1	6.1	6.1	6.1
Expected volatility	38.6%	31.8%	38.2%-38.6%	29.3%-31.8%	38.5%–38.7%	38.2%
Expected dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

The weighted-average grant-date fair value of options granted during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021 was $1.72 and ~~2020 was $3.15 and $0.98~~$3.42 per share, respectively. Cash proceeds received upon the exercise of options were ~~$3,532~~$79 and ~~$955~~$574 during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively. The intrinsic value of stock options exercised during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021 was $76 and ~~2020 was $5,182 and $1,480,~~$805, respectively. The aggregate intrinsic value is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those stock options that had exercise prices lower than the fair value of the Company’s common stock.

A summary of RSU activity ~~under the Company’s 2011 Stock Incentive Plan (the “2011 Plan”) and the 2017 Plan~~ for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 is as follows:

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Value		Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Value
Unvested balance at January 1, 2021		4,231		$	5.43
Unvested balance at January 1, 2022									4,309		$	6.34
Granted		1,660			8.26				24			4.18
Vested		(1,241	)		6.15	$	10,149		(922	)		6.58	$	4,339
Forfeited		(270	)		4.68				(54	)		6.68
Unvested balance at September 30, 2021		4,380		$	6.34
Unvested balance at March 31, 2022									3,357		$	6.26

The Company withheld ~~779~~318 and ~~150~~593 shares of common stock in settlement of employee tax withholding obligations due upon the vesting of RSUs and PSUs during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively.

During the ~~nine~~three months ended ~~September 30,~~March 31, 2021, ~~and 2020,~~ the Company granted PSUs to certain employees that vest over a three-year period based on the achievement of performance goals and continued performance of services. The performance goals consist solely of market-based vesting conditions, determined by the Company’s level of achievement of pre-established parameters relating to the performance of the Company’s stock price as set by the Board of Directors. Vesting may occur at any time during the three-year period.

Compensation expense is based on the estimated value of the awards on the grant date, and is recognized over the period from the grant date through the expected vest dates of each vesting condition, both of which were estimated based on a Monte Carlo simulation model applying the following key assumptions:

~~A summary~~There were 0 grants, vestings or forfeitures of ~~PSU activity for~~PSUs during the ~~nine~~three months ended ~~September 30, 2021 is~~March 31, 2022. 442 PSUs were unvested as ~~follows:~~of March 31, 2022 and January 1, 2022, with a weighted-average grant date fair value of $7.89.

Over time, the Company has granted SARs that allow the holder the right, upon exercise, to receive in cash the amount of the difference between the fair value of the Company’s common stock at the date of exercise and the price of the underlying common stock at the date of grant of each SAR. The SARs vested over a four-year period from the date of grant and expire ten years from the date of grant. ~~During~~NaN SARs were granted or exercised during the ~~nine~~three months ended ~~September 30, 2021, 20 SARs were exercised with a fair value of $6.75 per share.~~March 31, 2022. As of ~~September 30, 2021,~~March 31, 2022, 200 outstanding and fully vested SARs were exercisable with a weighted-average fair value of ~~$2.29~~$1.27 per SAR. The fair value of the SAR liability as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 was ~~$458~~$255 and ~~$493,~~$358, respectively (see Note 7), and was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheets.

Stock-based compensation expense related to stock options, RSUs, SARs and PSUs for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ was classified in the condensed consolidated statements of operations and comprehensive (loss) income as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Cost of revenue	$	29	$	45	$	95	$	115	$	35	$	33
Research and development expenses		557		592		1,971		1,679		595		871
Selling, general and administrative expenses		3,112		2,845		9,179		7,704		1,998		2,549
Total stock-based compensation	$	3,698	$	3,482	$	11,245	$	9,498	$	2,628	$	3,453

The Company recognized stock-based compensation expense for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~ in the condensed consolidated balance sheet as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,					Three Months Ended March 31,
	2021			2020			2021		2020			2022			2021
Change in fair value of SAR Liability	$	(188	)	$	(14	)	$	100	$	(7	)	$	(103	)	$	348
Recognized as additional paid-in capital		3,886			3,496			11,145		9,505			2,731			3,105
Total stock-based compensation	$	3,698		$	3,482		$	11,245	$	9,498		$	2,628		$	3,453

As of ~~September 30, 2021,~~March 31, 2022, there was ~~$25,442~~$19,642 of unrecognized compensation cost related to outstanding stock options, RSUs, SARs and PSUs, which is expected to be recognized over a weighted-average period of ~~2.67~~2.51 years.

Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:

	Three Months Ended September 30,					Nine Months Ended September 30,				Three Months Ended March 31,
	2021			2020		2021		2020		2022			2021
Numerator:
Net (loss) income attributable to common stockholders, basic and diluted	$	(876	)	$	3,473	$	1,680	$	1,607	$	(32,584	)	$	5,749
Denominator:
Weighted-average shares used to compute net (loss) income per share attributable to common stockholders, basic		85,660			83,302		84,985		83,437		84,583			84,242
Dilutive effect of stock options		—			1,125		1,765		1,207		—			1,978
Dilutive effect of restricted stock units		—			1,039		2,198		726		—			2,348
Weighted-average shares used to compute net (loss) income per share attributable to common stockholders, diluted		85,660			85,466		88,948		85,370		84,583			88,568
Net (loss) income per share attributable to common stockholders:
Basic	$	(0.01	)	$	0.04	$	0.02	$	0.02	$	(0.39	)	$	0.07
Diluted	$	(0.01	)	$	0.04	$	0.02	$	0.02	$	(0.39	)	$	0.06

The following potential common shares ~~presented based on amounts outstanding at each period end,~~ were excluded from the computation of diluted net (loss) income per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive:

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Options to purchase common stock		6,040		4,156		3,459		4,156		6,394		2,382
Unvested restricted stock units		4,380		1,001		723		1,001		3,357		1,221
Unvested performance-based stock units		442		983		—		983		442		—

The Company disaggregates its revenue by product and service in the condensed consolidated statements of operations and comprehensive (loss) income. Performance obligations related to product revenue are recognized at a point in time, while performance obligations related to service revenue are recognized over time. The Company also disaggregates its revenue based on geographic locations of its customers, as determined by the customer’s shipping address, summarized as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
North America:
United States	$	40,671	$	32,036	$	101,534	$	90,825
U.S.									$	13,535	$	36,912
Canada		11,087		6,428		61,875		15,170		15,759		26,238
Total North America		51,758		38,464		163,409		105,995		29,294		63,150
Europe, Middle East and Africa:		6,547		6,047		19,478		27,493		6,280		6,353
Asia-Pacific:
Australia		24,329		38,889		68,527		86,848		16,518		23,398
Other		8,832		10,014		24,526		31,884		8,180		6,801
Total Asia-Pacific		33,161		48,903		93,053		118,732		24,698		30,199
Latin America		7,753		12,333		20,286		20,500		4,127		4,575
Total revenue⁽¹⁾	$	99,219	$	105,747	$	296,226	$	272,720	$	64,399	$	104,277

The Company also disaggregates its revenue based on product line summarized as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
Product revenue:
Wireless	$	43,070	$	26,825	$	116,081	$	62,992	$	21,056	$	39,688
Fixed telco		20,187		34,005		51,209		75,756		11,715		14,885
Cable		24,495		32,911		94,729		100,879		19,774		39,225
Total product revenue		87,752		93,741		262,019		239,627		52,545		93,798
Service revenue:
Wireless		1,141		2,396		3,416		5,244		1,475		591
Fixed telco		825		441		3,474		992		1,524		1,606
Cable		9,501		9,169		27,317		26,857		8,855		8,282
Total service revenue		11,467		12,006		34,207		33,093		11,854		10,479
Total revenue	$	99,219	$	105,747	$	296,226	$	272,720	$	64,399	$	104,277

As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company had short-term capitalized contract costs of ~~$96~~$124 and ~~$95,~~$90, respectively, which are included in prepaid expenses and other current assets and had long-term capitalized contract costs of ~~$67~~$64 and ~~$70,~~$58, respectively, which are included in other assets in the accompanying condensed consolidated balance sheets. During the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ amortization expense associated with capitalized contract costs was $29 and $23, ~~and $76,~~ respectively,~~and during the nine months ended September 30, 2021 and 2020 was $75 and $524, respectively, all of~~ which was recorded to selling, general and administrative expenses in the accompanying condensed consolidated statements of operations and comprehensive (loss) income.

Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue when the Company satisfies its performance obligations, consistent with the above methodology. For the three ~~and nine~~ months ended ~~September 30,~~March 31, 2022, the Company recognized $5,636of revenue that was included in deferred revenue as of December 31, 2021. For the three months ended March 31, 2021, the Company recognized ~~$1,726and $13,706, respectively,~~$7,010 of revenue that was included in deferred revenue as of December 31, 2020. ~~For the three and nine months ended September 30, 2020, the Company recognized $9,857and $20,194, respectively, of revenue that was included in deferred revenue as of December 31, 2019.~~

The Company receives payments from customers based upon contractual billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for both completed and partially completed performance obligations that may not have been invoiced. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company included contract assets of ~~$781~~$409 and ~~$771, respectively, which is netted with deferred revenue in the accompanying condensed consolidated balance sheets.~~$95, respectively.

As of ~~September 30, 2021,~~March 31, 2022, the aggregate remaining amount of revenue expected to be recognized related to unsatisfied or partially unsatisfied performance obligations was ~~$20,929,~~$25,613, which consists of deferred revenue. The Company expects approximately ~~76%~~75% of this amount to be recognized in the next twelve months with the remaining amount to be recognized over the next two to five years.

The Company’s customary payment terms are generally 90 days or less. If the Company provides extended payment terms that represent a significant financing component, the Company adjusts the amount of promised consideration for the time value of money using an appropriate discount rate and recognizes interest income separate from the revenue recognized on contracts with customers. During the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the Company recorded interest income of $6$5 and ~~$10,~~$6, respectively, ~~and during the nine months ended September 30, 2021 and 2020, the Company recorded interest income of $14 and $57, respectively, all of~~ which ~~were~~was recorded in the condensed consolidated statements of operations and comprehensive (loss) income.

The Company operates as 1 operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the Company’s chief operating decision maker, or decision-making group, in deciding how to allocate resources and assess performance. The Company has determined that its chief operating decision maker is its President and Chief Executive Officer. The Company’s chief operating decision maker reviews the Company’s financial information on a consolidated basis for purposes of allocating resources and assessing financial performance. Since the Company operates as one operating segment, all required financial segment information can be found in these condensed consolidated financial statements.

	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
United States	$	17,431	$	20,988
U.S.					$	16,473	$	17,089
China		3,144		2,986		2,907		3,118
Australia		2,236		2,849		1,762		2,027
Other		1,836		2,057		1,218		1,274
Total property and equipment, net	$	24,647	$	28,880	$	22,360	$	23,508

Rongke Xie, who serves as ~~Deputy~~ General Manager of Guangzhou Casa Communication Technology LTD (“Casa China”), a subsidiary of the Company, is the sister of Lucy Xie, the Company’s Senior Vice President of Operations and a member of the Company’s board of directors. Casa China paid Rongke Xie ~~$187~~$37 and ~~$153~~$33 in total compensation during the ~~nine~~three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively, for her services as an employee.

To date, the Company has granted to Rongke Xie 116 RSUs which vest over four annual periods. The grant-date fair value of the awards totaled $500, which is recorded as stock-based compensation expense over the vesting period of the awards. During the three months ended ~~September 30,~~March 31, 2022 and 2021, ~~and 2020,~~ the Company recognized selling, general and administrative expenses of ~~$28~~$31 and $25 ~~related to these awards, and during the nine months ended September 30, 2021 and 2020, the Company recognized selling, general and administrative expenses of $78 and $62~~ related to these awards.

The Company has, in the ordinary course of business, agreed to defend and indemnify certain customers against third-party claims asserting (i) infringement of certain intellectual property rights, which may include patents, copyrights, trademarks or trade secrets, and (ii) certain other harms caused by the acts or omissions of the Company.

As permitted under Delaware law, the Company indemnifies its officers, directors and employees for certain events or occurrences that happen by reason of their relationship with or position held at the Company.

As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the Company had not experienced any material losses related to these indemnification obligations and 0 material claims were outstanding where a contingent loss was considered to be probable or reasonably estimable. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related liabilities were recorded in its condensed consolidated financial statements.

The complete response to this section regarding legal proceedings is incorporated by reference herein to Part II Item I in this 10-Q.

~~Revolving Credit Facility~~Securities Purchase Agreement with Verizon Ventures LLC

On ~~October 25, 2021,~~April 18, 2022, the Company ~~repaid all outstanding borrowings under~~entered into a Securities Purchase Agreement (the “SPA”) with Verizon Ventures LLC providing for the ~~revolving credit facility utilizing funds held in cash and cash equivalents in the condensed consolidated balance sheets as~~private placement of ~~September 30, 2021. Repayment~~an aggregate of 9,323 shares (the “Shares”) of the ~~revolving credit facility included $6,500~~Company’s common stock, par value $0.001 per share, at a price of ~~outstanding principal~~$4.24 per share, for an aggregate purchase price of approximately $39,530. The Company is required to prepare and $7file a resale registration statement with the Securities and Exchange Commission (the “SEC”) within 45 days of ~~outstanding interest on~~ the ~~payoff date. As noted in Note 10,~~ ~~Debt~~,closing of the full $6,500 outstanding balance was included in current portion of long-term debt, net of unamortized debt issuance costs on the condensed consolidated balance sheets as of September 30, 2021 and December 31, 2020.SPA.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read together with our condensed consolidated financial statements and related notes and other financial information included elsewhere in this Quarterly Report on Form 10-Q. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report on Form 10-Q, particularly in the section titled “Risk Factors.” For discussion comparing the period ended ~~September 30,~~March 31, 2021 and March 31, 2020, ~~and September 30, 2019,~~ please refer to our Quarterly Report on form 10-Q, filed with the SEC on ~~October 29, 2020.~~April 30, 2021.

~~Our solutions are conceived, designed and built to enable~~With our CSP customers to offer high bandwidth data services to their subscribers, and to transform their networks to meet the growing demand for bandwidth and to enable the introduction of new revenue-generating services. We offer physical, virtual and cloud-native 5G ~~broadband~~infrastructure and customer premise networking equipment ~~for~~solutions, we help our CSP customers transform and expand their public and private high-speed data and multi-service communications ~~networks.~~networks so they can meet the growing demand for bandwidth and new services. Our core and edge ~~broadband~~convergence technology enables CSPs and enterprises to cost-effectively and dynamically increase ~~data~~ network speed, ~~for their subscribers,~~ add bandwidth capacity and new services, reduce network complexity, and reduce operating and capital ~~expenditures.~~expenditures regardless of access technology.

We offer scalable solutions that can meet the evolving bandwidth needs of our customers and their subscribers. Our first installation in a service provider’s network frequently involves deploying our broadband products in only a portion of the provider’s network and, for our cable products, with only a fraction of the capacity of our products enabled at the time of initial installation. Over time, our customers have generally expanded the use of our solutions to other areas of their networks to extend network coverage or increase network capacity.

Our solutions are commercially deployed in over 70 countries by more than 475 customers, including regional service providers as well as some of the world’s largest Tier 1 CSPs, serving millions of subscribers.

The ongoing COVID-19 pandemic presents various risks to us, ~~not all of which we are able to fully evaluate or even to foresee at the current time, and~~ which could continue to have a material effect upon the estimates and judgments relied upon by management in preparing these condensed consolidated financial statements. While we remain fully operational, during the three ~~and nine~~ months ended ~~September 30, 2021,~~March 31, 2022, the effects of the COVID-19 pandemic on the global supply chain had a significant adverse effect on our financial results. In particular, certain of our products utilize components ~~for which there has been increased~~whose availability was significantly exceeded by global demand. As a result, ~~throughout 2021, and increasingly~~ during the three months ended ~~September 30, 2021,~~March 31, 2022, we ~~began~~continued to see shortages of supply that resulted in our inability to fulfill certain customer orders within normal lead times. This adversely impacted our revenue and operating results for the three ~~and nine~~ months ended ~~September 30, 2021.~~March 31, 2022. Additionally, shipping bottlenecks and delays further negatively affected our ability to timely fulfill customer orders, thereby delaying our ability to consummate sales and recognize revenue. We have also seen, in some cases, significant increases in shipping costs. While we continue to work with our supply chain, contract manufacturers, logistics partners and customers to minimize the extent of such impacts, we expect the effects of global supply chain issues to continue and cannot predict when such effects will subside. This may prevent us from being able to fulfill our customers’ orders in a timely manner or at all, which could lead to one or more of our customers cancelling their orders. At this time, we are neither able to estimate the extent of these impacts nor predict whether our efforts to minimize or contain them will be successful. We intend to continue to monitor our business very closely for any effects of COVID-19 for as long as necessary.

In addition to the negative impact on our business from global supply chain constraints related to COVID-19, we saw certain benefits that included decreases in certain operating expenses, such as travel and trade show expense, and benefited from certain U.S. government tax relief measures, discussed further below, during the year ended December 31, 2020, andFor the three ~~and nine~~ months ended ~~September 30, 2021. We expect these benefits to gradually diminish as the various geographies in which we operate begin to recover from the pandemic.~~

~~For the nine months ended September 30,~~March 31, 2021, we were able to benefit from the CARES Act that was signed into law on March 27, 2020. The CARES Act, among other things, includes tax provisions relating to refundable payroll tax credits, deferment of employer’s Social Security payments, net operating loss utilization and carryback periods, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property (QIP). For the ~~nine~~three months ended ~~September 30,~~March 31, 2021, we recognized a reduction to cost of goods sold of ~~$0.6~~$0.3 million and a

reduction in operating expenses of ~~$4.3~~$2.1 million, in connection with a payroll tax credit under the CARES Act. ~~For the nine months ended September 30, 2021 and 2020, we recognized an income tax benefit of $7.1 million and $9.3 million, respectively (see Note 9 to our accompanying financial statements).~~ We will continue to evaluate the impact of the CARES Act on our financial position, results of operations, and cash flows.

Due to the above circumstances and as described generally in this Quarterly Report on Form 10-Q, our results of operations for the three ~~and nine~~ months ended ~~September 30, 2021~~March 31, 2022 are not necessarily indicative of the results to be expected in future periods. Management cannot predict the full impact of the ongoing COVID-19 pandemic on our sales channels, supply chain, manufacturing and distribution, or on economic conditions generally, including the effects on our current and potential

customers, who may temporarily accelerate or curtail spending on investments in current and/or new technologies, delay new equipment evaluations and trials ~~cancel orders,~~ and possibly delay payments based on liquidity concerns, all of which could have a material impact on our business in the future. Similarly, our supply chain and our contract manufacturers could continue to be affected, which could cause further disruptions to our ability to meet customer demand or delivery schedules. For the three ~~and nine~~ months ended ~~September 30, 2021,~~March 31, 2022, we did see certain delays in our supply chain that adversely impacted delivery schedules to our customers. If COVID-19 were to have such effects in the future, there would likely be a material adverse impact on our financial results, liquidity and capital resource needs. This uncertainty makes it challenging for management to estimate the future performance of our business, particularly in the near to medium term and the impact of COVID-19 could have a material adverse impact on our results of operations in the near to medium term.

The following tables set forth our consolidated results of operations in dollar amounts and as percentages of total revenue for the periods shown:

Three Months Ended September 30,

Nine Months Ended September 30,

2021

2020

2021

2020

(in thousands)

(in thousands)

Revenue:

Product

$
87,752

$
93,741

$
262,019

$
239,627

Service

11,467

12,006

34,207

33,093

Total revenue

99,219

105,747

296,226

272,720

Cost of revenue⁽¹⁾:

Product

57,372

51,947

150,515

130,602

Service

1,223

1,206

3,532

3,741

Total cost of revenue

58,595

53,153

154,047

134,343

Gross profit

40,624

52,594

142,179

138,377

Operating expenses:

Research and development⁽¹⁾

21,578

21,823

63,479

63,722

Selling, general and administrative⁽¹⁾

21,029

21,630

64,492

67,731

Total operating expenses

42,607

43,453

127,971

131,453

(Loss) income from operations

(1,983
)

9,141

14,208

6,924

Other income (expense), net

(4,181
)

(3,269
)

(12,308
)

(10,750
)
(Loss) income before (benefit from) provision for income taxes

(6,164
)

5,872

1,900

(3,826
)
(Benefit from) provision for income taxes

(5,288
)

2,399

220

(5,433
)
Net (loss) income

$
(876
)

$
3,473

$
1,680

$
1,607

	Three Months Ended March 31,
	2022			2021
	(in thousands)
Revenue:
Product	$	52,545		$	93,798
Service		11,854			10,479
Total revenue		64,399			104,277
Cost of revenue⁽¹⁾:
Product		36,228			47,026
Service		1,492			1,211
Total cost of revenue		37,720			48,237
Gross profit		26,679			56,040
Operating expenses:
Research and development⁽¹⁾		22,673			21,606
Selling, general and administrative⁽¹⁾		22,329			21,880
Total operating expenses		45,002			43,486
(Loss) income from operations		(18,323	)		12,554
Other income (expense), net		(3,909	)		(4,479	)
(Loss) income before provision for income taxes		(22,232	)		8,075
Provision for income taxes		10,352			2,326
Net (loss) income	$	(32,584	)	$	5,749

	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended March 31,
	2021		2020		2021		2020		2022		2021
	(in thousands)				(in thousands)				(in thousands)
Cost of revenue	$	29	$	45	$	95	$	115	$	35	$	33
Research and development expense		557		592		1,971		1,679		595		871
Selling, general and administrative expense		3,112		2,845		9,179		7,704		1,998		2,549
Total stock-based compensation expense	$	3,698	$	3,482	$	11,245	$	9,498	$	2,628	$	3,453

	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2021			2020			2022			2021
	(as a percentage of total revenue)						(as a percentage of total revenue)						(as a percentage of total revenue)
Revenue:
Product		88.4	%		88.6	%		88.5	%		87.9	%		81.6	%		90.0	%
Service		11.6			11.4			11.5			12.1			18.4			10.0
Total revenue		100.0			100.0			100.0			100.0			100.0			100.0
Cost of revenue:
Product		57.8			49.1			50.8			47.9			56.3			45.1
Service		1.2			1.1			1.2			1.4			2.3			1.2
Total cost of revenue		59.1			50.3			52.0			49.3			58.6			46.3
Gross profit		40.9			49.7			48.0			50.7			41.4			53.7
Operating expenses:
Research and development		21.7			20.6			21.4			23.4			35.2			20.7
Selling, general and administrative		21.2			20.5			21.8			24.8			34.7			21.0
Total operating expenses		42.9			41.1			43.2			48.2			69.9			41.7
(Loss) income from operations		(2.0	)		8.6			4.8			2.5			(28.5	)		12.0
Other income (expense), net		(4.2	)		(3.1	)		(4.2	)		(3.9	)		(6.1	)		(4.3	)
(Loss) income before (benefit from) provision for income taxes		(6.2	)		5.6			0.6			(1.4	)
(Benefit from) provision for income taxes		(5.3	)		2.3			0.1			(2.0	)
(Loss) income before provision for income taxes														(34.5	)		7.7
Provision for income taxes														16.1			2.2
Net (loss) income		(0.9	)%		3.3	%		0.6	%		0.6	%		(50.6	)%		5.5	%

Percentages in the table above are based on actual values. As a result, some totals may not sum due to rounding.

Three Months Ended ~~September 30, 2021~~March 31, 2022 Compared to the Three Months Ended ~~September 30, 2020~~March 31, 2021

	Three Months Ended September 30,																Three Months Ended March 31,
	2021					2020					Change						2022					2021					Change
	Amount		% of Total			Amount		% of Total			Amount			%			Amount		% of Total			Amount		% of Total			Amount			%
	(dollars in thousands)																(dollars in thousands)
Revenue:
Product	$	87,752		88.4	%	$	93,741		88.6	%	$	(5,989	)		(6.4	)%	$	52,545		81.6	%	$	93,798		90.0	%	$	(41,253	)		(44.0	)%
Service		11,467		11.6	%		12,006		11.4	%		(539	)		(4.5	)%		11,854		18.4	%		10,479		10.0	%		1,375			13.1	%
Total revenue	$	99,219		100.0	%	$	105,747		100.0	%	$	(6,528	)		(6.2	)%	$	64,399		100.0	%	$	104,277		100.0	%	$	(39,878	)		(38.2	)%
Revenue by geographic region:
North America	$	51,758		52.2	%	$	38,464		36.4	%	$	13,294			34.6	%	$	29,294		45.5	%	$	63,150		60.6	%	$	(33,856	)		(53.6	)%
Europe, Middle East and Africa		6,547		6.6	%		6,047		5.7	%		500			8.3	%		6,280		9.8	%		6,353		6.1	%		(73	)		(1.1	)%
Asia-Pacific		33,161		33.4	%		48,903		46.2	%		(15,742	)		(32.2	)%		24,698		38.4	%		30,199		29.0	%		(5,501	)		(18.2	)%
Latin America		7,753		7.8	%		12,333		11.7	%		(4,580	)		(37.1	)%		4,127		6.3	%		4,575		4.3	%		(448	)		(9.8	)%
Total revenue	$	99,219		100.0	%	$	105,747		100.0	%	$	(6,528	)		(6.2	)%	$	64,399		100.0	%	$	104,277		100.0	%	$	(39,878	)		(38.2	)%

	Three Months Ended March 31,				Change
	2022		2021		Amount			%
Product revenue:
Wireless	$	21,056	$	39,688	$	(18,632	)		(46.9	)%
Fixed telco		11,715		14,885		(3,170	)		(21.3	)%
Cable		19,774		39,225		(19,451	)		(49.6	)%
Total product revenue		52,545		93,798		(41,253	)		(44.0	)%
Service revenue:
Wireless		1,475		591		884			149.6	%
Fixed telco		1,524		1,606		(82	)		(5.1	)%
Cable		8,855		8,282		573			6.9	%
Total service revenue		11,854		10,479		1,375			13.1	%
Total revenue	$	64,399	$	104,277	$	(39,878	)		(38.2	)%

Three Months Ended September 30,

Change

2021

2020

Amount

%

Product revenue:

Wireless

$
43,070

$
26,825

$
16,245

60.6
%
Fixed telco

20,187

34,005

(13,818
)

(40.6
)%
Cable

24,495

32,911

(8,416
)

(25.6
)%
Total product revenue

87,752

93,741

(5,989
)

(6.4
)%
Service revenue:

Wireless

1,141

2,396

(1,255
)

(52.4
)%
Fixed telco

825

441

384

87.1
%
Cable

9,501

9,169

332

3.6
%
Total service revenue

11,467

12,006

(539
)

(4.5
)%
Total revenue

$
99,219

$
105,747

$
(6,528
)

(6.2
)%

Product revenues during the three months ended ~~September 30, 2021~~March 31, 2022 were adversely affected by supply chain delays across all of our markets. Wireless and cable revenues ~~increased despite such delays,~~also decreased significantly due to ~~increased~~decreased revenues from certain Tier 1 customers in the period, ~~including increased sales~~as well as timing of certain end of life products that are not expected to derive significant revenues in future periods. In addition to the impact of supply chain delays, our fixed telco revenue declined due to decreased revenues from one Tier 1 customer, whose planned network buildout is nearing its completion. The decline in cable revenue was primarily the result of the aforementioned supply chain delays.orders.

The ~~decrease~~increase in service revenue was primarily due to ~~decreased sales of services~~increased support renewals in the three months ended ~~September 30, 2021~~March 31, 2022 as compared to the three months ended ~~September 30, 2020.~~March 31, 2021.

	Three Months Ended September 30,				Change					Three Months Ended March 31,				Change
	2021		2020		Amount		%			2022		2021		Amount			%
	(dollars in thousands)									(dollars in thousands)
Cost of revenue:
Product	$	57,372	$	51,947	$	5,425		10.4	%	$	36,228	$	47,026	$	(10,798	)		(23.0	)%
Service		1,223		1,206		17		1.4	%		1,492		1,211		281			23.2	%
Total cost of revenue	$	58,595	$	53,153	$	5,442		10.2	%	$	37,720	$	48,237	$	(10,517	)		(21.8	)%

	Three Months Ended September 30,																Three Months Ended March 31,
	2021					2020					Change						2022					2021					Change
	Amount		Gross Margin			Amount		Gross Margin			Amount			Gross Margin (bps)			Amount		Gross Margin			Amount		Gross Margin			Amount			Gross Margin (bps)
	(dollars in thousands)																(dollars in thousands)
Gross profit:
Product	$	30,380		34.6	%	$	41,794		44.6	%	$	(11,414	)		(1,000	)	$	16,317		31.1	%	$	46,772		49.9	%	$	(30,455	)		(1,880	)
Service		10,244		89.3	%		10,800		90.0	%		(556	)		(70	)		10,362		87.4	%		9,268		88.4	%		1,094			(100	)
Total gross profit	$	40,624		40.9	%	$	52,594		49.7	%	$	(11,970	)		(880	)	$	26,679		41.4	%	$	56,040		53.7	%	$	(29,361	)		(1,230	)

The increase in cost of product revenue and the decrease in gross margin was due to product mix, with a lower proportion of higher margin software ~~products and increased lower margin wireless customer premise equipment~~ product ~~sales.~~revenue in the three months ended March 31, 2022 as compared to the three months ended March 31, 2021.

Cost of service revenue and service gross margin remained relatively consistent period over period.

	Three Months Ended September 30,						Change						Three Months Ended March 31,						Change
	2021			2020			Amount			%			2022			2021			Amount		%
	(dollars in thousands)												(dollars in thousands)
Research and development	$	21,578		$	21,823		$	(245	)		(1.1	)%	$	22,673		$	21,606		$	1,067		4.9	%
Percentage of revenue		21.7	%		20.6	%								35.2	%		20.7	%

The ~~decrease~~increase in research and development expense was primarily due to a ~~$1.0 million decrease in purchases of research and development materials. This decrease was partially offset by a $0.8~~$1.8 million increase in personnel costs, driven by the impact of a ~~cash flow hedge~~reduction in ~~2020 and~~payroll taxes due to a ~~pension benefit relief in China~~CARES Act credit of $1.3 million during the three months ended ~~September 30, 2020,~~March 31, 2021, which did not repeat in 2022, increased salaries and bonus of $0.8 million due to increased headcount and annual salary increases in 2022, net of decreased stock-based compensation of $0.3 million. Partially offsetting this increase was a decrease in purchases of research and development materials of $0.5 million and a decrease in depreciation of $0.3 million during the three months ended March 31, 2022 as compared to the three months ended March 31, 2021.

	Three Months Ended September 30,						Change						Three Months Ended March 31,						Change
	2021			2020			Amount			%			2022			2021			Amount		%
	(dollars in thousands)												(dollars in thousands)
Selling, general and administrative	$	21,029		$	21,630		$	(601	)		(2.8	)%	$	22,329		$	21,880		$	449		2.1	%
Percentage of revenue		21.2	%		20.5	%								34.7	%		21.0	%

The ~~decrease~~increase in selling, general and administrative expense was primarily ~~driven by a $0.5 million decrease~~due to an increase in personnel costs ~~due to a $1.4~~of $0.8 million, ~~decrease in commissions, which was partially offset~~driven by ~~an increase of $0.4 million in salaries and benefits mainly due to~~ the impact of a ~~cash flow hedge~~reduction in ~~2020,~~payroll taxes due to a CARES Act credit of $0.7 million during the three months ended March 31, 2021, which did not repeat in 2022, an increase of $0.2 million in travel expenses and increased commissions expense of ~~$0.2~~$0.5 million, ~~and an increase~~net of a decrease of $0.6 million in stock-based compensation ~~of $0.3 million. In addition, depreciation~~expense. Trade show expense ~~and professional fees decreased $0.4 million and $0.2 million, respectively, partially offset by an increase in other taxes of~~also increased $0.5 million during the three months ended ~~September 30,~~March 31, 2022. These increases were partially offset by decreased depreciation expense of $0.2 million, decreased other taxes of $0.2 million and decreased professional fees of $0.3 million during the three months ended March 31, 2022 as compared to the three months ended March 31, 2021.

	Three Months Ended September 30,						Change						Three Months Ended March 31,						Change
	2021			2020			Amount			%			2022			2021			Amount		%
	(dollars in thousands)												(dollars in thousands)
Other income (expense), net	$	(4,181	)	$	(3,269	)	$	(912	)		27.9	%	$	(3,909	)	$	(4,479	)	$	570		(12.7	)%
Percentage of revenue		(4.2	)%		(3.1	)%								(6.1	)%		(4.3	)%

The change in other income (expense), net was primarily due to a ~~$0.4~~$0.5 million ~~increase~~decrease in foreign exchange losses ~~due~~attributable to fluctuations in the Australian dollar and the China Renminbi exchange ~~rates, a $0.3~~rates. Interest expense also decreased $0.1 million ~~decrease in other income~~ due to ~~a non-recurring research and development grant received~~lower overall debt balances in the three months ended ~~September 30, 2021 and an increase of $0.2 million in interest expense due~~March 31, 2022 as compared to ~~increased interest rates.~~the three months ended March 31, 2021.

The ~~(benefit from) income taxes~~enactment of the Tax Cuts and Jobs Act in December 2017, requires companies to capitalize all of their research and development costs incurred in tax years beginning after 2021. As a result, research and development costs can no longer be expensed as incurred for ~~the three months ended September 30, 2021 compared to the~~tax purposes, and must be capitalized and amortized, 5 years for domestic research and 15 years for international. The change in provision for income taxes for the three months ended ~~September 30, 2020~~March 31, 2022, compared to the three months ended March 31, 2021, was primarily due to ~~a discrete benefit of $7.1 million recorded in~~ the ~~three months ended September 30, 2021 associated with a~~ change in ~~estimate of our prior~~tax law, which results in significant forecasted U.S. income tax for the year ~~taxable net operating loss that~~and a significant corresponding increase in deferred tax assets, which is ~~able to be carried back as part of the CARES Act.~~offset by a full valuation allowance. The change in the ~~(benefit from) provision for income taxes was also impacted by changes in the jurisdictional mix of earnings period over period.~~

~~Nine Months Ended September 30, 2021 Compared to the Nine Months Ended September 30, 2020~~

Nine Months Ended September 30,

2021

2020

Change

Amount

% of Total

Amount

% of Total

Amount

%

(dollars in thousands)

Revenue:

Product

$
262,019

88.5
%

$
239,627

87.9
%

$
22,392

9.3
%
Service

34,207

11.5
%

33,093

12.1
%

1,114

3.4
%
Total revenue

$
296,226

100.0
%

$
272,720

100.0
%

$
23,506

8.6
%
Revenue by geographic region:

North America

$
163,409

55.2
%

$
105,995

38.9
%

$
57,414

54.2
%
Europe, Middle East and Africa

19,478

6.6
%

27,493

10.1
%

(8,015
)

(29.2
)%
Asia-Pacific

93,053

31.4
%

118,732

43.5
%

(25,679
)

(21.6
)%
Latin America

20,286

6.8
%

20,500

7.5
%

(214
)

(1.0
)%
Total revenue

$
296,226

100.0
%

$
272,720

100.0
%

$
23,506

8.6
%

Nine Months Ended September 30,

Change

2021

2020

Amount

%

Product revenue:

Wireless

$
116,081

$
62,992

$
53,089

84.3
%
Fixed telco

51,209

75,756

(24,547
)

(32.4
)%
Cable

94,729

100,879

(6,150
)

(6.1
)%
Total product revenue

262,019

239,627

22,392

9.3
%
Service revenue:

Wireless

3,416

5,244

(1,828
)

(34.9
)%
Fixed telco

3,474

992

2,482

250.2
%
Cable

27,317

26,857

460

1.7
%
Total service revenue

34,207

33,093

1,114

3.4
%
Total revenue

$
296,226

$
272,720

$
23,506

8.6
%

The increase in product revenue was primarily attributable to continued increased demand for our wireless products. The increase in wireless revenue was partially offset by decreased revenue from our fixed telco products, which is due to decreased demand from a Tier 1 customer that is completing its network buildout, and decreased revenue from our cable products, which have been adversely affected by supply chain delays.

The overall increase in service revenue was primarily due to increased support renewals and sales of services in cable and fixed telco, which was partially offset by a decline in wireless service revenue that was due to an increase in sales of certain wireless customer premise equipment products, for which we do not sell service contracts.

The increase in cost of product revenue was attributable to increased revenue. The overall product gross margin decline for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020 was due to product mix, with lower margin wireless customer premise equipment products comprising a larger percentage of total revenue.

The decrease in cost of service revenue and increase in service gross margin were primarily due to a decrease in utilization of third-party professional services in the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020.

The decrease in research and development expense was mainly due to a $1.6 million decrease in purchases of research and development materials. This decrease was partially offset by increased personnel costs of $0.7 million, caused primarily by increased salaries and benefits of $3.3 million during the nine months ended September 30, 2021 due to the impact of a cash flow hedge in 2020 and an increase in average headcount, partially offset by a reduction in payroll taxes due to a CARES Act credit of $2.6 million during the nine months ended September 30, 2021. Professional services increased $0.3 million in the nine months ended September 30, 2021. Allocated facilities and depreciation costs increased by $0.3 million driven by increased average headcount.

The decrease in selling, general and administrative expense was primarily driven by a decrease of $1.2 million in professional services and a $1.9 million decrease in depreciation expense as assets that became fully depreciated were not replaced. Personnel costs decreased by $0.5 million for the nine months ended September 30, 2021, driven by a $3.7 million decrease in commissions, a $0.7 million decrease in travel due to COVID-19, and a $1.6 million decrease in payroll taxes due to a CARES Act credit during the nine months ended September 30, 2021, partially offset by increases in salaries and benefits of $4.0 million, driven by the impact of a cash flow hedge in 2020, increased average headcount, and increased stock-based compensation of $1.5 million. These decreases were partially offset by an increase in other taxes of $0.5 million during the three months ended September 30, 2021.

The change in other income (expense), net was primarily due to a $2.0 million increase in foreign exchange losses due to fluctuations in the Australian dollar and the China Renminbi exchange rates and a $0.6 million decrease in interest income due to lower interest rates, partially offset by a $0.8 million decrease in interest expense due to decreases in both the outstanding principal balance and the interest rate on our term loan facility.

The change in the (benefit from) provision for income taxes was primarily due to a discrete tax benefit of $9.3 million recorded during the nine months ended September 30, 2020 associated with the enactment of the CARES Act, partially offset by a discrete benefit of $7.1 million recorded during the nine months ended September 30, 2021 associated with a change in estimate of our prior year taxable net operating loss that is able to be carried back as part of the CARES Act. The change in the (benefit from) provision for income taxes was also impacted by changes in the jurisdictional mix of earnings period over period.

Our principal sources of liquidity have been and continue to be our cash and cash equivalents and cash flows from operations. The following tables set forth our cash and cash equivalents and working capital as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 and our cash flows for the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 and ~~2020:~~2021:

	September 30, 2021		December 31, 2020		March 31, 2022		December 31, 2021
	(in thousands)				(in thousands)
Consolidated Balance Sheet Data:
Cash and cash equivalents	$	156,460	$	157,455	$	168,580	$	154,703
Working capital		269,110		251,573		236,725		264,157

	Nine Months Ended September 30,						Three Months Ended March 31,
	2021			2020			2022			2021
	(in thousands)						(in thousands)
Consolidated Cash Flow Data:
Net cash provided by operating activities	$	15,197		$	51,644
Net cash provided by (used in) operating activities							$	18,097		$	(5,155	)
Net cash used in investing activities		(4,404	)		(4,102	)		(966	)		(2,252	)
Net cash used in financing activities		(11,905	)		(5,767	)		(3,354	)		(4,819	)

As of ~~September 30, 2021,~~March 31, 2022, we had cash, cash equivalents and restricted cash of ~~$157.5~~$171.7 million and net accounts receivable of ~~$80.9~~$48.2 million. We maintain a $25.0 million revolving credit facility, under which we have drawn $6.5 million and utilized $1.5 million of available credit, which we used as collateral for two stand-by letters of credit, leaving $17.0 million of available credit as of September 30, 2021.

Our primary source of cash from operating activities has been cash collections from our customers. We expect cash flows from operating activities to be affected by ~~increases and decreases~~changes in sales volumes and timing of collections, and by purchases and shipments of inventory. Our primary uses of cash from operating activities have been for personnel costs and investment in our selling, general and administrative departments and research and development. Future cash outflows from operating activities may increase as a result of further investment in research and development and selling, general and administrative requirements, ~~and~~as well as increases in personnel costs as we continue to grow our business by enhancing our existing products and introducing new products.

During the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022, cash provided by operating activities was ~~$15.2~~$18.1 million, primarily resulting from ~~our net income of $1.7 million, net non-cash adjustments of $21.9 million and~~ net cash ~~used~~provided by changes in our operating assets and liabilities of ~~$8.4~~$43.8 million and net non-cash adjustments of $6.8 million, partially offset by our net loss of $32.6 million. ~~The net~~Net cash ~~used~~provided by changes in our operating assets and liabilities during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was primarily due to a ~~$17.6~~$37.5 million decrease in accounts receivable due to collections during the period; a $21.3 million decrease in prepaid income taxes; a $9.0 million increase in accrued income taxes; and a $4.1 million increase in deferred revenue due to the timing of revenue recognition. These sources of cash were partially offset by a $13.7 million decrease in accounts payable due to timing of vendor payments; a ~~$6.1~~$13.7 million decrease in accrued ~~expenses;~~expenses due to the timing of certain accrual payments; a ~~$5.9~~$0.5 million increase in ~~prepaid income taxes;~~inventory; and a ~~$1.6~~$0.2 million increase in prepaid expenses and other assets; and a $1.6 million decrease in accrued income taxes. These uses were partially offset by a $13.2 million decrease in accounts receivable due to collections during the period; a $9.3 million net decrease in inventory; and a $1.9 million increase in deferred revenue due to the timing of revenue recognition.assets.

Our investing activities have consisted primarily of expenditures for lab and computer equipment and software to support the development of new products. In addition, our investing activities include expansion of and improvements to our facilities. As our business expands, we expect that we will continue to invest in these areas.

Net cash used in investing activities during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was ~~$4.4~~$1.0 million, consisting of purchases of property and equipment and software licenses.

Net cash used in financing activities during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022 was ~~$11.9~~$3.4 million, consisting primarily of ~~debt principal repayments of $9.0 million and~~ employee taxes paid related to net share settlement of equity awards of ~~$6.3~~$1.5 million, primarily due to ~~PSUs~~certain RSUs that vested during the ~~nine~~three months ended ~~September 30, 2021~~March 31, 2022.; repurchases of treasury stock of $1.2 million; and debt principal repayments of $0.8 million. These payments were partially offset by proceeds from the exercise of stock options of ~~$3.5~~$0.1 million.

In July 2015, we entered into an $8.0 million commercial mortgage loan agreement, which matured on July 1, 2020. On July 1, 2020, we paid in full the remaining $6.5 million in unpaid principal and accrued interest under the mortgage loan with funds drawn upon our revolving credit facility. The annual interest rate on the loan was 3.5%, and the loan was repayable in 60 monthly installments of principal and interest based on a 20-year amortization schedule.

On December 20, 2016, we entered into a credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, various lenders and JPMorgan Chase Bank, N.A. and Barclays Bank PLC, as joint lead arrangers and joint bookrunners, providing for:

As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, we had borrowings of ~~$279.0~~$277.5 million and ~~$288.0~~$278.2 million, respectively, outstanding under the ~~term loan facility. As of September 30,~~Term Loan. On December 20, 2021, ~~and December 31, 2020 we had borrowings of $6.5 million under~~ the revolving credit facility which were drawn down to fund the repayment of our commercial mortgage loan. However, on October 25, 2021, we repaid the full balance of outstanding borrowings under the revolving credit facility with cash and cash equivalents in the condensed consolidated balance sheets as of September 30, 2021. As of September 30, 2021 and December 31, 2020, we had also used $1.5 million of available credit under the revolving credit facility for two stand-by letters of credit, one which serves as collateral to one of our customers pursuant to a contractual obligation and one which is used as collateral for operating leases in Australia. In addition, we may, subject to certain conditions, including the consent of the administrative agent and the institutions providing such increases, increase the facilities by an unlimited amount so long as we are in compliance with specified leverage ratios, or otherwise by up to $70.0 million.matured.

Borrowings under the ~~facilities~~Term Loan bear interest at a floating rate, which can be either a Eurodollar rate plus an applicable margin or, at our option, a base rate (defined as the highest of (x) the JPMorgan Chase, N.A. prime rate, (y) the federal funds effective rate, plus one-half percent (0.50%) per annum and (z) a one-month Eurodollar rate plus 1.00% per annum) plus an applicable margin. The applicable margin for borrowings under the ~~term loan facility~~Term Loan is 4.00% per annum for Eurodollar rate loans (subject to a 1.00% per annum interest rate floor) and 3.00% per annum for base rate loans. The applicable margin for borrowings under the revolving credit facility is 1.75% per annum for Eurodollar rate loans and 0.75% per annum for base rate loans, subject to reduction based on our maintaining specified net leverage ratios. The interest rates payable under the facilities are subject to an increase of 2.00% per annum during the continuance of any payment default.

For Eurodollar rate loans, we may select interest periods of one, three or six months or, with the consent of all relevant affected lenders, twelve months. Interest will be payable at the end of the selected interest period, but no less frequently than every three months within the selected interest period. Interest on any base rate loan is not set for any specified period and is payable quarterly. We have the right to convert Eurodollar rate loans into base rate loans and the right to convert base rate loans into Eurodollar rate loans at our option, subject, in the case of Eurodollar rate loans, to breakage costs if the conversion is effected prior to the end of the applicable interest period. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the interest rate on the ~~term loans~~Term Loan was 5.00% per annum, which was based on a ~~three-month and six-month~~one-month Eurodollar rate, ~~respectively,~~ at the applicable floor of 1.00% per annum plus the applicable margin of 4.00% per annum for Eurodollar rate loans. As of September 30, 2021, the interest rate on the revolving credit facility was 1.83% per annum, which was based on a one-month Eurodollar rate of 0.08% per annum plus the applicable margin of 1.75% per annum for Eurodollar rate loans. As of December 31, 2020, the interest rate on the revolving credit facility was 2.12% per annum, which was based on the six-month Eurodollar rate of 0.37% per annum plus the applicable margin of 1.75% per annum for Eurodollar rate loans.

~~The term loan~~Term Loan matures on December 20, 2023 ~~and the revolving credit facility matures on December 20, 2021. The term loan facility~~ is subject to amortization in equal quarterly installments, which commenced on March 31, 2017, of principal in an annual aggregate amount equal to 1.0% of the original principal amount of the term loans of $300.0 million, with the remaining outstanding balance payable at the date of maturity.

Voluntary prepayments of principal amounts outstanding under the ~~term loan facility~~Term Loan are permitted at any time; however, if a prepayment of principal is made with respect to a Eurodollar loan on a date other than the last day of the applicable interest period, we are required to compensate the lenders for any funding losses and expenses incurred as a result of the prepayment. ~~Prior to the revolving credit facility maturity date, funds borrowed under the revolving credit facility may be borrowed, repaid and reborrowed, without premium or penalty.~~

In addition, we are required to make mandatory prepayments under the facilities with respect to (i) 100% of the net cash proceeds from certain asset dispositions (including casualty and condemnation events) by us or certain of our subsidiaries, subject to certain exceptions and reinvestment provisions, (ii) 100% of the net cash proceeds from the issuance or incurrence of any additional debt by us or certain of our subsidiaries, subject to certain exceptions, and (iii) 50% of our excess cash flow, as defined in the credit agreement, subject to reduction upon our achievement of specified performance targets. ~~In accordance with these provisions, a mandatory prepayment of $6.8 million was paid on April 2, 2021.~~

The ~~facilities are~~Term Loan is secured by, among other things, a first priority security interest, subject to permitted liens, in substantially all of our assets and all of the assets of certain of our subsidiaries and a pledge of certain of the stock of certain of our subsidiaries, in each case subject to specified exceptions. The ~~facilities contain~~Term Loan contains customary affirmative and negative covenants, including certain restrictions, onsuch as our ability to pay dividends, ~~and, with respect only to the revolving credit facility, a financial covenant requiring us to maintain a specified~~certain of which are based upon our total net leverage ratio, in the event that on the last day of any fiscal quarter, we have utilized more than 30% of our borrowing capacity under the revolving credit facility (subject to certain exceptions). The term loan facility contains a cross-default provision, whereby, if repayment of borrowings under the revolving credit facility are accelerated due to a default of the net leverage ratio covenant, repayment of the outstanding term loan balance could also be accelerated. Because the financial covenant under the revolving credit facility only applies if outstanding utilization thereunder exceeds 30% of the total borrowing capacity on the last day of each fiscal quarter, this cross-default provision has the effect of limiting our ability to utilize more than 30% of our total borrowing capacity under the revolving credit facility of $25.0 million if both our net leverage ratio exceeds the maximum permitted by the agreement and we would not otherwise be able to reduce our outstanding utilization of the revolving credit facility to below the 30% testing threshold prior to the last day of any quarter.ratio. As of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, we were in compliance with all applicable covenants of the ~~facilities. We do not expect to require the use of the revolving credit facility to fund operations during the next 12 months.~~Term Loan.

Of our total cash and cash equivalents of ~~$156.5~~$171.7 million as of ~~September 30, 2021, $143.6~~March 31, 2022, $107.8 million was held by our foreign subsidiaries. The ~~Tax Cuts and Jobs Act, or~~ TCJA established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. As of ~~September 30, 2021,~~March 31, 2022, we had ~~$25.5~~$29.7 million of undistributed earnings in China that are not indefinitely reinvested. The remaining unremitted earnings of our foreign subsidiaries are either indefinitely reinvested or could be remitted with an immaterial tax cost.

The TCJA included a provision requiring companies to capitalize all of their research and development costs incurred in tax years beginning after 2021. As a result, research and development costs can no longer be expensed as incurred for tax purposes, and must be capitalized and amortized, 5 years for domestic research and 15 years for international. While it is possible that Congress may retroactively defer, modify or repeal the law change, any such actions would be accounted for in the period of enactment. Absent such Congressional action, this change in tax law will result in significant cash tax payments and have a material adverse effect on our liquidity.

On April 18, 2022, we entered into a Securities Purchase Agreement (the “SPA”) with Verizon Ventures LLC providing for the private placement of an aggregate of 9.3 million shares (the “Shares”) of our common stock, par value $0.001 per share, at a price of $4.24 per share, for an aggregate purchase price of approximately $39.5 million.

We are required to prepare and file a resale registration statement with the Securities and Exchange Commission (the “SEC”) within 45 days of the closing of the SPA, and intend to use the net proceeds from the private placement for general corporate purposes.

On February 21, 2019, we announced a stock repurchase program under which we were authorized to repurchase up to $75.0 million of our common stock. During the three months ended March 31, 2022, we repurchased approximately 0.2 million shares for a total cost of approximately $1.2 million. During the three months ended March 31, 2021 we did not repurchase any shares. As of March 31, 2022, approximately $60.2 million remained authorized for repurchases of our common stock

under the stock repurchase program. The stock repurchase program has no expiration date and does not require us to purchase a minimum number of shares, and we may suspend, modify or discontinue the stock repurchase program at any time without prior notice.

We believe our existing cash and cash equivalents and anticipated cash flows from future operations ~~and liquidity available from our revolving credit facility~~ will be sufficient to meet our working capital and capital expenditure needs and debt service obligations for at least the next 12 months. Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth, the timing and extent of spending on research and development efforts and other business initiatives, purchases of capital equipment to support our growth, the expansion of sales and marketing activities, expansion of our business through acquisitions or our investments in complementary products, technologies or businesses, the use of working capital to purchase additional inventory, the timing of new product introductions, market acceptance of our products and overall economic conditions. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. In the event additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all.

On February 21, 2019, we announced a stock repurchase program under which we were authorized to repurchase up to $75.0 million of our common stock. During the nine months ended September 30, 2020, we repurchased approximately 1.2 million shares for a total cost of approximately $3.0 million. During the nine months ended September 30, 2021 we did not repurchase any shares. As of September 30, 2021, approximately $70.2 million remained authorized for repurchases of our common stock under the stock repurchase program. The stock repurchase program has no expiration date and does not require us to purchase a minimum number of shares, and we may suspend, modify or discontinue the stock repurchase program at any time without prior notice.

Our material contractual obligations include our term loan, ~~facility, revolving credit facility,~~ operating leases and purchase agreements with our contract manufacturers and suppliers. There have been no material changes to our contractual obligations and commitments from those disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2020.~~2021.

We prepare our condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States. The preparation of condensed consolidated financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related

disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management.

Other than our ~~policies related to stock-based compensation and our~~ adoption of ASU ~~2020-06,~~2021-08, as described in Note 2 of the above notes to the condensed consolidated financial statements, there have been no material changes to our critical accounting policies and estimates from those disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2020.~~2021.

Refer to the “Summary of Significant Accounting Policies” footnote within our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for our analysis of recent accounting pronouncements that are applicable to our business.

Market risk is the risk of loss to future earnings, values or future cash flows that may result from changes in the price of a financial instrument. The value of a financial instrument may change as a result of changes in interest rates, exchange rates, commodity prices, equity prices and other market changes. We are exposed to market risk related to changes in foreign currency exchange rates and interest rates. We currently mitigate certain foreign currency exchange rate risks with derivative instruments and enter into exchange rate hedging arrangements to manage certain of the risks described below. We do not engage in foreign currency speculation.

We have accounts receivables denominated in foreign currencies, and our operations outside of the United States incur their operating expenses in foreign currencies. To date, the majority of our product sales and inventory purchasesThere have been ~~denominated in U.S. dollars. For~~no material changes to our subsidiaries in Ireland and Australia, the U.S. dollar is the functional currency. For each of our other foreign subsidiaries, the functional currency is the local currency. During the nine months ended September 30, 2021 and 2020, we incurred foreign currency transaction (losses) gains of $(1.4) million and $0.7 million, respectively, primarilymarket risks related to unrealized and realized foreign currency (losses) gains for accounts receivable denominated in foreign currencies and operating expenses that are denominated in local currencies. We recorded these foreign currency transaction (losses) gains as a component of other income (expense), net in our condensed consolidated statements of operations and comprehensive (loss) income. We believe that a 10% change in the exchange rate between either the U.S. dollar and Euro or the U.S. dollar and Australian dollar would not materially impact our operating results or financial position.

Our foreign currency risk management practices are principally intended to mitigate the potential financial impact of changes in the value of transactions and balances denominated in foreign currencies resulting from changes in foreign currency exchange, ~~rates. From time to time we enter into cash flow hedges, which utilize foreign currency forward contracts to hedge specific forecasted transactions of~~interest rate sensitivity and inflation as disclosed in our ~~foreign subsidiaries with~~Annual Report on Form 10-K for the ~~goal of protecting our budgeted revenues and expenses against foreign currency exchange rate changes compared to our budgeted rates. During the three and nine months~~fiscal year ended September 30, 2020, we settled two cash flow hedges which were used to hedge specific operating cash flows denominated in Australian dollars. No cash flow hedges were settled or outstanding during the three or nine months ended September 30, 2021.

Additionally, from time to time, we enter into other foreign currency forward contracts with the goal of protecting outstanding receivables denominated in currencies other than the U.S. dollar. As of September 30, 2021 we had two currency forward contracts outstanding with notional amounts totaling 1.4 million Euros that will mature in the fourth quarter of 2021 and first quarter of 2022 and we expect to continue to hedge certain significant transactions denominated in currencies other than the U.S. dollar in the future.

The success of our foreign currency risk management program depends upon forecasts of transaction activity denominated in various currencies. To the extent that these forecasts are overstated or understated during periods of currency volatility, we could experience unanticipated foreign currency gains or losses that could have a material impact on our results of operations. Furthermore, our failure to identify new exposures and hedge against them in an effective manner may result in material foreign currency gains or losses.

~~Our cash and cash equivalents as of September 30, 2021 and~~ December 31, ~~2020 consisted of cash maintained in FDIC-insured operating accounts as well as investments in money market mutual funds and certificates of deposit. We also~~2021.

have policies requiring that we invest in high-quality issuers, limit our exposure to any individual issuer, and ensure adequate liquidity. Our primary exposure to market risk for our cash equivalents is interest income sensitivity, which is primarily affected by changes in the general level of U.S. interest rates. However, we do not believe a sudden change in the interest rates for our cash equivalents would have a material impact on our financial condition, results of operations or cash flows.

We have a credit agreement that provides us with a term loan facility of $300.0 million and a revolving credit facility of up to $25.0 million in revolving credit loans and letters of credit. Borrowings under the facilities bear interest at a floating rate, which can be either a Eurodollar rate plus an applicable margin or, at our option, a base rate (defined as the highest of (x) the JPMorgan Chase, N.A. prime rate, (y) the federal funds effective rate, plus one-half percent (0.50%) per annum and (z) a one-month Eurodollar rate plus 1.00% per annum) plus an applicable margin. The applicable margin for borrowings under the term loan facility is 4.00% per annum for Eurodollar rate loans (subject to a 1.00% per annum interest rate floor) and 3.00% per annum for base rate loans. The applicable margin for borrowings under the revolving credit facility is 1.75% per annum for Eurodollar rate loans and 0.75% per annum for base rate loans, subject to reduction based on our maintaining of specified net leverage ratios.

As of September 30, 2021, we had borrowings of $279.0 million outstanding under the term loan facility, bearing interest at a rate of 5.00% per annum, which was based on a three-month Eurodollar rate at the applicable floor of 1.00% per annum plus the applicable margin of 4.00% per annum for Eurodollar rate loans. Changes in interest rates could cause interest charges on our term loan facility to fluctuate. Based on the amount of borrowings outstanding as of September 30, 2021, an increase or decrease of 10% in the Eurodollar rate would have no impact on our earnings and cash flows, as the interest rate in effect at September 30, 2021 on the term loan facility was at the applicable floor of 1.00% per annum and would continue to be in effect with a change of 10%.

~~On July 1, 2020, we drew down upon our revolving credit facility under our term loan agreement in the amount of $6.5 million. As noted in Note 10,~~ ~~Debt~~, borrowings under the revolving credit facility mature on December 21, 2021 and the applicable margin for borrowings under the revolving credit facility is 1.75% per annum for Eurodollar rate loans. The interest rate on the outstanding borrowings as of September 30, 2021 was 1.83%, which was based on a one-month Eurodollar rate of 0.08% per annum plus the applicable margin of 1.75% per annum for Eurodollar rate loans. An increase or decrease of 10% in the one-month Eurodollar rate would result in a pre-tax change to our earnings and cash flows of less than $0.1 million per year, assuming that such rate was to remain in effect for a year.

We do not believe that inflation has had a material effect on our business to date. However, as more fully described in Item 2 above, global demand for the base materials utilized by our suppliers and supply chain risks could result in significant increases in the costs of the components we purchase, and we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, operating results and financial condition.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that as of such date, our disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

From time to time, we are a party to various litigation matters and subject to claims that arise in the ordinary course of business including, for example, patent infringement lawsuits by non-practicing entities. In addition, third parties may from time to time assert claims against us in the form of letters and other communications.

On May 29, 2019, John Shen filed a putative shareholder class action complaint in the Massachusetts Superior Court of Essex County, John Shen v. Casa Systems, Inc, et al., Civil Action No. 1977CV00787, against us; certain of our current and former executive officers and directors; Summit Partners, our largest investor; and the underwriters from our December 15, 2017, initial public offering, or IPO. On July 3, 2019, Mirza R. Baig filed a similar putative shareholder class action complaint in the Massachusetts Superior Court of Essex County, Mirza R. Baig v. Casa Systems, Inc., Civil Action No. 1977CV00961, against the same defendants. The two matters were subsequently consolidated and transferred to the Business Litigation Session of the Massachusetts Superior Court, Suffolk County, John Shen v. Casa Systems, Inc, et al., Civil Action No. 19-CV-03203-BLS2 and Mirza R. Baig v. Casa Systems, Inc., Civil Action No. 19-CV-03204-BLS2. The complaints, as later amended on November 12, 2019, purported to be brought on behalf of all purchasers of our common stock in and/or traceable to the IPO. The complaints generally alleged that (i) each of the defendants violated Section 11 and/or Section 12(a)(2) of the Securities Act of 1933, as amended, or the Securities Act, because documents related to the IPO, including our registration statement and prospectus were materially misleading by containing untrue statements of material fact and/or omitting to state material facts necessary to make such statements not misleading and (ii) the individual defendants and Summit Partners acted as controlling persons within the meaning and in violation of Section 15 of the Securities Act. Plaintiffs sought, among other things, compensatory damages, costs and expenses, including counsel and expert fees, rescission or a rescissory measure of damages, and equitable and injunctive relief. On January 12, 2021, the court granted motions to dismiss filed by the defendants. On February 22, 2021, plaintiffs filed notice of appeal.

On August 9, 2019, Donald Hook filed a putative shareholder class action lawsuit in the Supreme Court of the State of New York, County of New York, Donald Hook, et al., v. Casa Systems, Inc. et al., Index No. 654548/2019, against the same defendants named in the Shen and Baig matters. The complaint, as later amended on November 22, 2019, purports to be brought on behalf of all purchasers of our common stock in and/or traceable to our IPO and generally alleges that (i) each of the defendants violated Section 11 and/or Section 12(a)(2) of the Securities Act because documents related to our IPO including our registration statement and prospectus were materially misleading by containing untrue statements of material fact and/or omitting to state material facts necessary to make such statements not misleading and (ii) the individual defendants and Summit Partners acted as controlling persons within the meaning and in violation of Section 15 of the Securities Act. Plaintiff sought, among other things, compensatory damages, costs and expenses, including counsel and expert fees, rescission or a rescissory measure of damages, disgorgement, and equitable and injunctive relief. On August 30, 2021, the court granted motions to dismiss filed by the defendants. On September 30, 2021, plaintiff filed notice of appeal. By letter dated April 11, 2022, plaintiff voluntarily withdrew its unperfected appeal.

On August 13, 2019, Panther Partners, Inc. filed a putative shareholder class action lawsuit in the Supreme Court of the State of New York, New York County, Panther Partners, Inc., et al., v. Jerry Guo et al., Index No 654585/2019, against us, certain of our current and former executive officers and directors, and the underwriters from our April 30, 2018 follow-on offering of common stock, which we refer to as our “Follow-on Offering.” The complaint, as later amended on November 22, 2019, purports to be brought on behalf of all purchasers of our common stock in our Follow-on Offering and generally alleges that (i) each of the defendants, other than Abraham Pucheril, violated Section 11 of the Securities Act, and each of the defendants violated Section 12(a)(2) of the Securities Act, because documents related to our Follow-on Offering, including our registration statement and prospectus, were materially misleading by containing untrue statements of material fact and/or omitting to state material facts necessary to make such statements not misleading and (ii) the individual defendants acted as controlling persons within the meaning and in violation of Section 15 of the Securities Act. Plaintiff sought, among other things, compensatory damages, costs and expenses, including counsel and expert fees, rescission or a rescissory measure of damages, and equitable and injunctive relief. On October 4, 2021, the court granted motions to dismiss filed by the defendants. By letter dated April 8, 2022, plaintiff voluntarily withdrew its unperfected appeal.

No amounts have been accrued for any of the putative class action lawsuits referenced above as of ~~September 30, 2021,~~March 31, 2022, as we do not believe the likelihood of a material loss is probable. Although the ultimate outcome of these matters cannot be predicted with certainty, the resolution of any of these matters could have a material impact on our results of operations in the period in which such matter is resolved.

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in “Part I, Item 1A Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2020,~~2021, or the ~~2020~~2021 10-K, which could materially affect our business, financial condition or future results. ~~Other than the updated risk factors described below, there~~There have been no material changes from the risk factors previously disclosed in the ~~2020~~2021 10-K.

~~The coronavirus outbreak could negatively impact our operations and have an adverse effect on our revenues and/or results of operations.~~

The COVID-19 pandemic presents various risks to us, not all of which we are able to fully evaluate or even to foresee at the current time, and which could have a material effect upon the estimates and judgments relied upon by management in preparing these condensed consolidated financial statements. While we remain fully operational, during the three and nine months ended September 30, 2021, the effects of the COVID-19 pandemic on the global supply chain had a significant adverse effect on our financial results. In particular, certain of our products utilize components, for which there has been increased global demand. As a result, throughout 2021, and increasingly during the three months ended September 30, 2021, we began to see shortages of supply that resulted in our inability to fulfill certain customer orders within normal lead times. This adversely impacted our revenue and operating results for the three and nine months ended September 30, 2021. While we continue to work with our supply chain, contract manufacturers, and customers to minimize the extent of such impacts, we expect the effects of global supply chain issues to continue and cannot predict when such effects will subside. This may prevent us from being able to fulfill our customers’ orders in a timely manner or at all, which could lead to one or more of our customers cancelling their orders. At this time, we are neither able to estimate the extent of these impacts nor predict whether our efforts to minimize or contain them will be successful. We intend to continue to monitor our business very closely for any effects of COVID-19 for as long as necessary.

Due to the above circumstances and as described generally in our 2020 Annual Report on Form 10-K, our results of operations for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected in future periods. Management cannot predict the full impact of the COVID-19 pandemic on our sales channels, supply chain, manufacturing and distribution, or on economic conditions generally, including the effects on our current and potential customers, who may curtail spending on investments in current and/or new technologies, delay new equipment evaluations and trials, cancel orders, and possibly delay payments based on liquidity concerns, all of which could have a material impact on our business in the future. Similarly, our supply chain and our contract manufacturers could be affected, which could cause disruptions to our ability to meet customer demand or delivery schedules. For the three and nine months ended September 30, 2021, we did see certain delays in our supply chain that adversely impacted delivery schedules to our customers. If COVID-19 were to have such effects in the future, there would likely be a material adverse impact on our financial results, liquidity and capital resource needs. This uncertainty makes it challenging for management to estimate the future performance of our business, particularly in the near to medium term and the impact of COVID-19 could have a material adverse impact on our results of operations in the near to medium term.

~~The coronavirus outbreak has resulted in an increase in demand for certain of our solutions, which may subside or decrease when the pandemic ends.~~

The pandemic and resulting lockdowns have resulted in an increase in demand for residential broadband services, which has in turn led to an increase in demand for certain of our solutions, including our fiber extension home network connection devices and our Fixed Wireless Access CPE devices. We also saw a shift in demand from our cable customers toward more I-CCAP chassis each quarter. That increase in demand contributed to our strong revenue performance in 2020 and has continued into 2021. We cannot guarantee that the heightened demand for residential broadband services will continue for the duration of the pandemic or after the pandemic ends. We similarly cannot guarantee that even to the extent the heightened demand for residential broadband services continues that we will continue to see heightened demand for our solutions. A decrease in demand for our solutions could have a material adverse impact on our revenue and results of operations.

On December 14, 2017, the Securities and Exchange Commission, or the SEC, declared our registration statement on Form S-1 (File No. 333-221658) for our initial public offering, or IPO, effective. The net offering proceeds to us from the IPO, after deducting underwriting discounts of $6.3 million and offering expenses payable by us totaling $4.1 million, were approximately $79.3 million. No offering discounts, commissions or expenses were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning 10.0% or more of any class of our equity securities or to any other affiliates. There has been no material change in the planned use of proceeds from our IPO as described in our final prospectus filed with the SEC on December 15, 2017 pursuant to Rule 424(b)(4). As of ~~September 30, 2021,~~March 31, 2022, we had not used any of the net offering proceeds and we have invested the proceeds into an investment portfolio with the primary objective of preserving principal and providing liquidity without significantly increasing risk.

The following table sets forth information with respect to repurchases of shares of our common stock during the three-month period ended ~~September 30, 2021:~~March 31, 2022:

Period

Total Number of
Shares Purchased

Average
Price Paid per
Share (1)

Total Number of
Shares Purchased
as Part of Publicly
Announced Plans or
Programs (2)

Approximate Dollar
Value of Shares
that May Yet Be
Purchased Under
the Plans or
Programs

(In thousands)

(In thousands)

(In thousands)

July 1 - July 31, 2021

—

$
—

—

$
70,208

August 1 - August 31, 2021

—

$
—

—

$
70,208

September 1 - September 30, 2021

—

$
—

—

$
70,208

Period	Total Number of Shares Purchased		Average Price Paid per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
	(In thousands)				(In thousands)		(In thousands)
January 1 - January 31, 2022		205	$	5.82		205	$	60,234
February 1 - February 28, 2022		—	$	—		—	$	60,234
March 1 - March 31, 2022		—	$	—		—	$	60,234

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Delaware		75-3108867
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
100 Old River Road Andover, Massachusetts		01810
(Address of principal executive offices)		(Zip Code)

Title of each class	Trading ~~Symbol~~Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	CASA	The Nasdaq Stock Market LLC

		Page
PART I.	FINANCIAL INFORMATION	3
Item 1.	Financial Statements	3
	Condensed Consolidated Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets as of ~~September 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021	3
	Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the Three ~~and Nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~	4
	Condensed Consolidated Statements of Stockholders' Equity for the Three ~~and Nine~~ months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~	5
	Condensed Consolidated Statements of Cash Flows for the ~~Nine~~Three months ended ~~September 30,~~March 31, 2022 and 2021 ~~and 2020~~	76
	Notes to Unaudited Condensed Consolidated Financial Statements	87
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2722
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3830
Item 4.	Controls and Procedures	4030
PART II.	OTHER INFORMATION	4131
Item 1.	Legal Proceedings	4131
Item 1A.	Risk Factors	4232
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	4332
Item 6.	Exhibits	4433
Signatures		4534

	~~Accounts Receivable, Net~~
	~~September 30, 2021~~			~~December 31, 2020~~
~~Customer A~~		21	%	*
~~Customer D~~	*				17	%

	September 30,			December 31,
	2021			2020
Current liabilities:
Term loan	$	3,000		$	9,775
Revolving credit facility		6,500			6,500
Current portion of principal payment obligations		9,500			16,275
Unamortized debt issuance costs, current portion		(1,079	)		(1,104	)
Current portion of long-term debt, net of unamortized debt issuance costs	$	8,421		$	15,171
Non-current liabilities:
Term loan	$	275,975		$	278,225
Unamortized debt issuance costs, non-current portion		(1,303	)		(2,140	)
Long-term debt, net of current portion and unamortized debt issuance costs	$	274,672		$	276,085

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☒

	September 30, 2021		September 30, 2020
Cash and cash equivalents	$	156,460	$	156,191
Restricted cash included in other assets		1,000		1,004
	$	157,460	$	157,195

	March 31, 2022		March 31, 2021
Cash and cash equivalents	$	168,580	$	144,961
Restricted cash included in other assets		3,101		1,008
	$	171,681	$	145,969

Year Ending December 31,
Remainder of 2021	$	7,250
2022		3,000
2023		275,225
Thereafter		—
	$	285,475

Year Ending December 31,
Remainder of 2022	$	2,250
2023		275,225
Thereafter		—
	$	277,475

				Equitable Adjustment Payments
				Nine Months Ended				Equitable Adjustment Liability(1)
Dividend Declaration Dates	Equitable Adjustment per share		Year of Final Vesting	September 30, 2021		September 30, 2020		As of September 30, 2021		As of December 31, 2020
November 30, 2017	$	0.5802	2021	$	42	$	136	$	1	$	30	��
May 10, 2017		1.1774	2021		53		176		—		31
December 27, 2016		2.3306	2020		2		295		—		2
June 17, 2016		0.5891	2020		—		54		—		—
Total				$	97	$	661	$	1	$	63

Exhibit Number		Description

3.1		Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-38324) filed on December 19, 2017)

3.2		By-laws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-38324) filed on December 19, 2017)

31.1*10.1		Offer Letter, dated March 2, 2022, by and between the Registrant and Ed Durkin (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-38324) filed on March 24, 2022)

31.1		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*31.2		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH		Inline XBRL Taxonomy Extension Schema Document

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

	CASA SYSTEMS, INC.

Date: ~~November 2, 2021~~May 4, 2022	By:	/s/ Jerry Guo
		Jerry Guo
		President, Chief Executive Officer and Chairman (Principal Executive Officer)

Date: ~~November 2, 2021~~May 4, 2022	By:	/s/ ~~Scott Bruckner~~Edward Durkin
		~~Scott Bruckner~~Edward Durkin
		Chief Financial Officer (Principal Financial Officer)